Publications

  1. Epstein JB, Moore DM, McPhail CWB.  How much does the public know about preventive dental health?  J Can Dent Assoc 1974; 40: 657-600.
  2. Epstein JB, Magrowski WD, McPhail CWB.  The role of radio and TV spot announcements in public health education.  Can J Public Health 1975; 66: 396-398
  3. Epstein JB.  Premedication and sedation techniques.  IADS Newsletter 1976; 4: 55-61.
  4. Epstein JB.  Cervical erosion and abrasion.  IADS Newsletter 1976; 4: 29-43
  5. Epstein JB.  Oral Medicine --viewpoint. College of Dental Surgeons of Saskatchewan Newsletter 1979; 5: 12-14.
  6. Epstein JB.  The mouth: A window on systemic disease.  Can Fam Physician 1980; 26: 953-957.
  7. Epstein JB, Pearsall NN, Truelove EL.  Quantitative relationships between Candida albicans in saliva and the clinical status of human subjects.  J Clin Microbiol 1980; 12 (3): 475-476.
  8. Epstein JB, Moore DM.  Oral health after periodontal therapy.  J Canada Dent Assoc 1980; 46: 703-707
  9. Epstein JB, Moore DM.  Patient knowledge and attitudes after periodontal therapy.  J Canada Dent Assoc 1980; 46: 709-711.
  10. Paul JR, Epstein JB.  White lesions of the oral cavity: An aid to accurate diagnosis.  Oral Health 1980; 70: 51-54,74
  11. Komiyama K, Epstein JB, Trew JA, Ross AS, Singer DL.  Hepatitis B surface antigen and antibody prevalence (a survey at the College of Dentistry, University of Saskatchewan).  J Can Dent Assoc 1981; 47: 40-45.
  12. Epstein JB, Pearsall NN, Truelove EL.  Oral candidiasis: Effects of antifungal therapy upon clinical signs and symptoms, salivary antibody and mucosal adherence.  Oral Surg Oral Med Oral Pathol 1981; 51: 32-37
  13. Epstein JB, Hatcher DC, Graham M.  Bone Scintigraphy of fibrosseous lesions of the jaw.  Oral Surg Oral Med Oral Pathol 1981; 51: 346-350.
  14. Epstein JB, Ruprecht A.  Bone Scintigraphy: An aid in the diagnosis and management of facial pain associated with osteo-arthrosis.  Oral Surg Oral Med Oral Pathol 1982; 53: 37-42
  15. Epstein JB.  Clinical trials of a sialagogue in humans: A preliminary report.  Spec Care Dentist 1982; 2: 17-19.
  16. Epstein JB, Kimura KH, Menard TW, Truelove EL, Pearsall NN.  Effects of Specific Antibodies on the Interaction between the fungus Candida albicans and human oral mucosa.  Arch Oral Biol 1982; 27: 469-474
  17. Epstein JB, Komiyama K, Trew JA, Ross AS.  Hepatitis B: A one year follow-up.  J Canada Dent Assoc 1982; 48: 327-330.
  18. Epstein JB.  Hepatitis B and dentistry.  In: Symposium on Hepatitis B, Symposium Highlight News, Communications Media for Education, Princeton Junction, New Jersey, 1982; 3
  19. Epstein JB, Decoteau WE, Wilkinson A.  Effect of Sialor in treatment of xerostomia in Sjogren's syndrome.  Oral Surg Oral Med Oral Pathol 1983; 56: 495-499.
  20. Epstein JB, Schubert MM, Hatcher DC.  Multiple neurofibromatosis: Report of a case.  Oral Surg Oral Med Oral Pathol 1983; 56: 560-562
  21. Epstein JB, Truelove EL, Izutzu KT.  Oral candidiasis: Pathogenesis and host defence.  Rev Infect Dis 1984; 6: 96-106.
  22. Epstein JB, Voss NJS, Stevenson-Moore P.  Maxillofacial manifestations in multiple myeloma.  Oral Surg Oral Med Oral Pathol 1984; 57: 267-271
  23. Epstein JB.  Understanding placebos in dentistry.  J Am Dent Assoc 1984; 109: 71-74.
  24. Epstein JB, Duchner BK, Bouchard S.  Hepatitis B and Canadian dental professionals.  J Canada Dent Assoc 1984; 50: 555-559
  25. Epstein JB.  Imaging of the TMJ: Clinical application.  Oral Surg Oral Med Oral Pathol 1985; 59: 356-357.
  26. Epstein JB.  Understanding placebos in dentistry: A study in development and implications.  Oral Health 1985; 75: 67-71
  27. Epstein JB, Strafehl DM, Stevenson-Moore P.  Use of intraoral prostheses in external beam radiation of oral and perioral cancer.  J Prosthet Dent 1985; 54: 100-107.
  28. Epstein JB, Priddy RW, Sparling T, Wadsworth L.  Oral manifestations in myelodysplastic syndrome.  Oral Surg Oral Med Oral Pathol 1986; 61: 446-470
  29. Epstein JB.  Placebe I odontolgien.  Nye Tidsskrift 1986; 5: 16-19.
  30. Epstein JB, Mathias RG.  Infection control in dental practice: Demands of the 1980's.  J Canada Dent Assoc 1986; 52: 695-699
  31. Epstein JB, Stevenson-Moore P.  Benzydamine hydrochloride in prevention and management of pain in oral mucositis associated with radiation therapy.  Oral Surg Oral Med Oral Pathol 1986; 62: 145-148.
  32. Epstein JB.  Oral and maxillofacial cancer pain.  Spec Care Dentist 1986; 6: 223-227
  33. Epstein JB, Komiyama K, Duncan D.  Oral topical steroids and secondary oral candidiasis.  J Oral Med 1986; 41: 223-227.
  34. Epstein JB, Wong FL, Stevenson-Moore P.  Osteoradionecrosis: Clinical experience and a proposal for classification.  J Oral Maxillofac Surg 1987; 45: 104-111
  35. Epstein JB, Wittenberg GJ.  Maxillofacial manifestations and management of arthrogryposis:  Literature review and case report.  J Oral Maxillofac Surg 1987; 45: 274-279.
  36. Epstein JB, Schubert M.  Synergistic effects of sialagogues in the management of xerostomia following radiation therapy.  Oral Surg Oral Med Oral Pathol 1987; 64: 179-182
  37. Epstein JB, Gangbar SJ.  Oral mucosal lesions in patients undergoing treatment for leukemia.  J Oral Med 1987; 43: 132-137.
  38. Epstein JB, Page JL, Anderson GH, Spinelli J.  The role of an immunoperoxidase technique in the diagnosis of oral herpes simplex virus infection in patients with leukemia.  Diagnostic Cytopathology 1987; 3: 205-209
  39. Epstein JB, Rea G, Wong FL, Spinelli J, Stevenson-Moore P.  Osteonecrosis:  Study of the relationship of dental extractions in patients receiving radiotherapy.  Head Neck Surg 1987; 10: 48-54.
  40. Epstein JB, Mathias RG.  Infectious disease in outpatient practice.  J Canada Dent Assoc 1987; 10: 767-772
  41. Epstein JB, Knowling MA, LeRiche JC.  Multiple gingival metastases from angiosarcoma of the breast. Oral Surg Oral Med Oral Pathol 1987; 64: 554-557.
  42. Epstein JB, Silverman S Jr.  Oral manifestations of human immunodeficiency virus infection:  Recognition and diagnosis.  J Canada Dent Assoc 1988; 54: 413-419
  43. Epstein JB.  Oral management of individuals with human immunodeficiency virus infection.  J Canada Dent Assoc 1988; 54: 423-427.
  44. Epstein JB, Rekart JL.  AIDS update: Oral findings.  BC Med J 1988; 30: 418-421.
  45. Wong F, Epstein JB.  Dental extractions and radiotherapy for head and neck cancers.  Oral Surg Oral Med Oral Pathol 1988; 66: 176-177.
  46. Epstein JB, Mathias RG.  Oral manifestations of human immunodeficiency virus infection.  Canada Family Physician 1988; 34: 1773-1780.
  47. Epstein JB, Priddy RW, Sherlock CH.  Hairy leukoplakia-like lesions in immunosuppressed patients following bone marrow transplantation.  Transplantation 1988; 46: 462-464.
  48. Epstein JB.  Benzydamine HCl in prevention of oropharyngeal mucositis in radiation therapy:  Literature review and clinical study.  Res Clin Forums 1988; 10: 91-97.
  49. Epstein JB.  Oral and pharyngeal candidiasis: Topical agents for management and prevention.  Postgrad Med 1989; 85: 257-270.
  50. Epstein JB, Stevenson-Moore P, Jackson SM, Mohamed JH, Spinelli JJ.  Prevention of oral mucositis in radiation therapy:  A controlled study with benzydamine hydrochloride rinse.  Int J Radiat Oncol Biol Phys 1989; 16: 1571-1575.
  51. Wong F, Epstein J, Millner A.  Treatment of oral leukoplakia with topical bleomycin:  A pilot study.  Cancer 1989; 64: 361-365.
  52. Epstein JB, Loh R, Stevenson-Moore P, McBride BC, Spinelli J.  Chlorhexidine rinse in prevention of dental caries in patients following radiation therapy.  Oral Surg Oral Med Oral Pathol 1989; 68: 401-405.
  53. Epstein JB, Rathee NN, Mathias RG.  Infection Control: Survey of dental health care workers.  Oral Health 1989; 79: 53-56.
  54. Epstein JB, Scully C.  Intralesional vinblastine for oral Kaposi's sarcoma in HIV infection.  Lancet 1989; 2: 1100-1101.
  55. Scully C, Epstein JB, Porter S.  Oral hairy leukoplakia.  Lancet 1989; 2: 1194.
  56. Epstein JB, Lozada-Nur F, McLeod WA, Spinelli J.  Oral Kaposi's sarcoma in acquired immunodeficiency syndrome.  Cancer 1989; 64: 2424-2430.
  57. Epstein JB.  Antifungal therapy in oropharyngeal mycotic infections.  Oral Surg Oral Med Oral Pathol 1990; 69: 32-41.
  58. Epstein JB.  Infection prevention in bone marrow transplantation and radiation patients.  NCI Monogr 1990; 9: 73-85.
  59. Epstein JB, Sherlock C, Page, JL, Spinelli J, Phillips G.  Clinical study of herpes simplex virus infection in leukemia.  Oral Surg Oral Med Oral Pathol 1990; 70: 38-43.
  60. Epstein JB.  Management of Aphthous-like Ulcers in HIV Disease.  AIDS Patient Care 1990; 4: 12-13.
  61. Scully C, Epstein JB, Porter S, Luker J.  Recognition of Oral Lesions of HIV Infection.  I. Candidiasis.  Br Dent J 1990; 170: 295-7.
  62. Scully C, Epstein JB, Porter S, Luker J.  Recognition of Oral Lesions of HIV Infection. 2. Hairy Leukoplakia and Kaposi's Sarcoma.  Br Dent J 1990; 170: 332-3.
  63. Scully C, Epstein JB, Porter S, Luker J.  Recognition of Oral Lesions of HIV Infection. 3.  Gingival and Periodontal disease and less common lesions.  Br Dent J 1990; 170: 370-2.
  64. Epstein JB, Scully C.  HIV infection: Clinical features and treatment of thirty-three homosexual men with Kaposi's sarcoma.  Oral Surg Oral Med Oral Pathol 1991; 71: 38-41.
  65. Noble MA, Gibson GB, Mathias RG, Epstein JB.  Hepatitis B and HIV infections in dental professionals: effectiveness of infection control procedures.  J Can Dent Assoc 1991; 57: 55-58.
  66. Epstein JB, McBride BC, Stevenson-Moore P, Merilees H, Spinelli J.  The efficacy of chlorhexidine gel in reductions of Streptococcus mutans and Lactobacillus species in patients treated with radiation therapy. Oral Surg Oral Med Oral Pathol 1991; 71: 172-8.
  67. Epstein JB, Sherlock CH, Greenspan JS.  Hairy leukoplakia-like lesions following bone-marrow transplantation.  Aids 1991; 5: 101-102.
  68. Epstein JB, Schubert MM, Scully C.  Evaluation and Treatment of Pain in Patients with Orofacial Cancer: A Review.  The Pain Clinic 1991; 4: 3-20.
  69. Williams PM, Epstein JB.  American Heart Association updates recommendations for prevention of infective endocarditis.  J Can Dent Assoc 1991; 57: 494-5.
  70. Epstein JB, Scully C.  Herpes simplex virus in immunocompromised patients: Growing evidence of drug resistance.  Oral Surg Oral Med Oral Pathol 1991; 72: 47-50.
  71. Epstein JB.  Report on the impact of HIV and other infectious agents on oral health care.  "The Suture Line," Alberta Dental Assistants Association Newsletter Summer 1991: 14.
  72. Epstein JB.  Antiviral therapeutics in dentistry.  Curr Opin Dent 1991; 1: 436-444.
  73. Scully C, Epstein J, Porter S, Cox M.  Viruses and chronic disorders involving the human oral mucosa.  Oral Surg Oral Med Oral Pathol 1991; 72: 537-44.
  74. Epstein JB, Phillips K, Sherlock CH.  Viral serology during bone marrow transplantation.  Viral Immunology 1991; 4: 133-7.
  75. American Association of Dental Schools, Clinical Sciences, Curriculum Development Committee.  Greenspan D, Dummett C, Epstein J, Komives B, Walker P, Zambon J.  Curriculum guidelines for the dental care management of patients with bloodborne.  J Dent Educ 1991; 55: 609-619.
  76. Epstein JB, Schubert M, Scully C.  Evaluation and treatment of pain in patients with orofacial cancer: A review. The Pain Clinic 1991; 4 (1): 3-20.
  77. Epstein JB.  Jaw Problems: Conservative Management.  Recovery 1992; 3: 10 (Insurance Corporation British Columbia).
  78. Epstein JB, Silverman S Jr.  Head and neck malignancies associated with HIV infection.  Oral Surg Oral Med Oral Pathol 1992; 73: 193-200.
  79. Epstein JB, Stevenson-Moore P, Scully C.  Management of xerostomia.  J Canada Dent Assoc 1992; 58: 140-143.
  80. Epstein JB, Porter SR, Scully C.  Non-A, non-B hepatitis and dentistry: A status report for the American Journal of Dentistry.  Am J Dent 1992; 5: 49-56.
  81. Epstein JB.  Cancers of the mouth.  Family Health 1992; 7(1): 36-8.
  82. Epstein JB, Scully C.  The role of saliva in oral health and the causes and effects of xerostomia.  J Can Dent Assoc  1992; 58: 217-21.
  83. Epstein J.  The dry mouth: clinical management.  Moisture Seekers Newsletter 1992; 9(3): 3.
  84. Epstein JB, Oral complications of cancer chemotherapy: etiology, recognition and management.  Can J Oncol 1992; 2: 83-95.
  85. Galler C, Epstein JB, Guze KA, Buckles D, Stevenson-Moore P.  The development of osteoradionecrosis from sites of periodontal disease activity: Report of 3 cases.  J Periodontol 1992; 63: 310-16.
  86. Epstein JB, Scully C, Porter SR.  The risk of transmission of Human Immunodeficiency Virus in dental practice.  Oral Health 1992 (May): 8.
  87. Epstein JB, Scully C.  Mammalian bites: Risk and Management.  Am J Dent 1992; 5: 167-171.
  88. Epstein JB, Scully C, Spinelli JJ.  Toluidine blue and Lugol's iodine application in the assessment of oral malignant disease and lesions at risk of malignancy.  J Oral Pathol Med 1992; 21: 160-3.
  89. Epstein JB.  Temporomandibular disorders, facial pain and headache following motor vehicle accidents.  J Canada Dent Assoc 1992; 58: 488-95.
  90. Epstein JB, Vickers L, Spinelli J, Reece D.  Efficacy of chlorhexidine and nystatin rinses in prevention of oral complications in leukemia and bone marrow transplantation.  Oral Surg Oral Med Oral Pathol 1992; 73: 682-9.
  91. Epstein JB, Sherlock CH, Wolber RA.  Cytomegalovirus-induced gingivitis.  Ann Intern Med 1992; 116: 1034.
  92. Epstein JB, Wong FL, Dickens A, Szasz I, Lepawsky M.  Bone and gallium scans in postradiotherapy osteonecrosis of the jaw.  Head Neck 1992; 14: 288-92.
  93. Addems A, Epstein JB, Damji S, Spinelli J.  The lack of efficacy of a foam brush in maintaining gingival health: a controlled study.  Spec Care Dentist 1992; 12: 103-106.
  94. Scully C, Epstein JB, Porter S.  Compliance with infection control procedures in a dental hospital clinic.  Br Dent J 1992; 173: 20-23.
  95. Sreebny LM, Banoczy J, Baum BJ, Edgar WM, Epstein JB, Fox PC, Larmas M.  Saliva: Its role on health and disease.  Int Dent J 1992; 42: 291-304.
  96. Epstein JB, Scully C.  Neoplastic disease in the head and neck of patients with AIDS.  Int J Oral Maxillofac Surg 1992; 21: 219-26.
  97. Epstein JB.  Terapia antimicotica en infecciones orofarineas.  Oral Diag 1992; 4: 30-35.
  98. Azizi BA, Epstein JB.  Oral hairy leukoplakia in immunocompromised patients.  AIDS Patient Care 1992; 6: 118-122.
  99. Epstein JB, Stevenson-Moore P.  A clinical comparative trial of saliva substitutes on radiation- induced salivary gland hypofunction.  Spec Care Dentist 1992; 12: 21-23.
  100. Epstein JB, Rea G.  The value of panoramic radiographic examination in patients with leukemia before medical management.  Oral Surg Oral Med Oral Pathol 1992; 74: 736-41.
  101. Christianson C, Epstein J, Mathias R.  A case of a hepatitis B infected practitioner.  J Canada Dent Assoc  1993; 59: 52-57.
  102. Epstein JB, Jones CK.  Presenting signs and symptoms of nasopharyngeal carcinoma.  Oral Surg Oral Med Oral Pathol 1993; 75: 32-36.
  103. Stevenson-Moore P, Epstein JB.  The management of teeth in irradiated sites.  Eur J Cancer Oral Oncol 1993; 29 (B): 39-43.
  104. Epstein JB.  Treatment of oral Kaposi's sarcoma with intralesional vinblastine.  Cancer 1993; 71: 1722-5.
  105. Epstein JB, Sherlock CH, Wolber RA.  Oral manifestations of cytomegalovirus infection.  Oral Surg Oral Med Oral Pathol  1993; 75: 443-51.
  106. Mathias RG, Marion SA, Epstein JB.  The causation of disease: HIV and AIDS.  J Canada Dent Assoc  1993; 59: 351-3.
  107. Epstein JB, Sherlock CH, Wolber RA.  Hairy leukoplakia after bone marrow transplantation.  Oral Surg Oral Med Oral Pathol 1993; 75:  690-5.
  108. Epstein JB, Nemanishen, G.  Temporomandibular disorders following motor vehicle accidents.  BC Med J 1993; 35: 588-91.
  109. Epstein JB, Freilich M, Le N.  Risk factors for oropharyngeal candidiasis in patients who receive radiation therapy for malignant conditions of the head and neck.  Oral Surg Oral Med Oral Pathol 1993; 76: 169-74.
  110. McKenzie M, Wong F, Epstein JB, Lepawsky M.  Hyperbaric oxygen and postradiation osteonecrosis of the mandible.  Eur J Cancer Oral Oncol 1993; 29B (3): 201-207.
  111. Epstein JB, Stewart KH.  Radiation therapy and pain in patients with head and neck cancer.  Eur J Cancer Oral Oncol 1993; 29B (3) 191-9.
  112. Schubert MM, Epstein JB, Lloid ME, Cooney E.  Oral infections due to cytomegalovirus in immunocompromised patients.  J Oral Pathol Med 1993; 22: 268-73.
  113. Epstein JB.  Epidemiology of bacterial endocarditis.  J Canad Dent Assoc Comminique 1993: Sept 11.
  114. Epstein J. Contributions In: Barron SR, Patrick DM, eds.  Information for physicians on managing patients with HIV infection and AIDS.  British Columbia Ministry of Health and Ministry Responsible for Seniors, 1993: 22, 24, 46-48.
  115. Epstein JB, Rea G, Sibau L, Sherlock CH.  Rotary dental instruments and the potential risk of transmission of infection: Herpes Simplex Virus.  J Am Dent Assoc 1993; 124: 55-59.
  116. Epstein JB, Scully C.  Cytomegalovirus: A virus of increasing relevance to oral medicine and pathology.  J Oral Pathol Med 1993; 22: 348-53.
  117. Epstein JB, Scully C.  Oral adverse effects of medical management in patients with HIV infection. AIDS Patient Care 1993; 7(6): 304 - 311.
  118. Epstein JB, Schubert MM.  Management of orofacial pain in cancer patients.  Eur J Cancer Oral Oncol 1993; 29B: 243-250.
  119. Epstein JB, Reece DE.  Topical cyclosporin A for treatment of oral chronic graft-versus-host disease.  Bone Marrow Transplant 1994; 13: 81-86.
  120. Epstein JB, Leziy S, Ransier A.  Periodontal pocketing in HIV-associated periodontitis.  Spec Care Dent 1993; 13 (6): 236-40.
  121. Epstein JB, Marcoe JH.  Topical application of capsaicin for treatment of oral neuropathic pain and trigeminal neuralgia.  Oral Surg Oral Med Oral Pathol 1994; 77: 135-40.
  122. Epstein JB, Schubert MM.  Management of orofacial pain in cancer patients.  Eur J Cancer Oral Oncol 1993; 29B: 243-250.
  123. Epstein JB, Ransier A, Lunn R, Spinelli J.  Enhancing the effect of oral hygiene with the use of a foam brush with chlorhexidine.  Oral Surg Oral Med Oral Pathol 1994; 77: 242-7.
  124. Epstein JB, Sherlock CH.  Hepatitis C: rapid progress in medicine and implications for dentistry.  J Canada Dent Assoc 1994; 60: 323-9.
  125. Epstein JB, Burchell JL, Emerton S, Le ND, Silverman S.  A clinical trial of bethanechol in patients with xerostomia after radiation therapy.  Oral Surg Oral Med Oral Pathol 1994; 77: 610-4.
  126. Bales JB, Epstein JB.  The role of malocclusion and orthodontics in temporomandibular disorders.  J Canada Dent Assoc 1994; 60: 899-905.
  127. Epstein JB.  Infectious disease, infection control and the effect of a Florida cluster of HIV infection.  J Canada Dent Assoc 1994; 60: 925-6.
  128. Epstein JB, Wong FLW, Millner A, Le ND.  Topical bleomycin treatment of oral leukoplakia: A randomized double-blind clinical trial.  Head Neck 1994; 16: 539-44.
  129. Epstein JB, Corbett T, Galler C, Stevenson-Moore P.  Surgical periodontal treatment in the radiotherapy-treated head and neck cancer patient.  Spec Care Dentist 1994; 14: 182-7.
  130. Kolbinson DA, Epstein JB.  Temporomandibular Disorders - An Overview for Pain Clinicians.  The Pain Clinic 1994; 7: 329-346.
  131. Epstein JB, Rea G, Sibau L, Sherlock CH, Le ND.  Assessing viral retention and elimination in rotary dental instruments.  J Am Dent Assoc 1995; 126:  87-92.
  132. Epstein JB, Mathias RG, Bridger DV.  Survey of knowledge of infectious disease and infection control practices of dental specialists.  J Canada Dent Assoc 1995; 61: 35-37, 40-44.
  133. Epstein JB, Fatahzadeh M, Matisic J, Anderson G.  Exfoliative cytology and electron microscopy in the diagnosis of hairy leukoplakia. Oral Surg Oral Med Oral Pathol 1995; 79: 564-9.
  134. Riben PD, Epstein JB, Mathias RG.  Dentistry and tuberculosis in the 1990s. J Canada Dent Assoc 1995;  61: 492-498.
  135. Epstein JB, Mathias RG, Gibson GB.  Survey to assess dental practitioners’ knowledge of infectious disease. J Canada Dent Assoc 1995; 61: 519 - 525.
  136. Epstein, JB, Silverman, S. The changing face of HIV infection: Charting the pattern of AIDS in Canada and the United States. J Canada Dent Assoc 1995; 61: 985 - 987.
  137. Gibson GB, Mathias RG, Epstein JB.  Compliance to recommended infection control procedures: Changes over six years among British Columbia dentists. J Canada Dent Assoc 1995; 61:  526 - 532.
  138. Ma R, Epstein JB, Emerton S, Hay JH. A Preliminary investigation of an association between dental restorations and carcinoma of the tongue. Eur J Cancer Oral Oncol 1995; 31B (4): 232-234.
  139. Ransier A, Epstein JB, Lunn R, Spinelli J.  A combined analysis of a toothbrush, foam brush and a chlorhexidine-soaked foam brush in maintaining oral hygiene.  Cancer Nurs 1995; 18 (5): 393 - 396.
  140. Epstein JB. Regional considerations in the treatment of Kaposi’s sarcoma. Drugs and Therapy Perspectives 1995; 6(2): 9.
  141. Epstein, JB. The future direction of dentistry: Increased emphasis on and recognition of medically necessary oral health care. Spec Care Dentist 1995; 15 (3): 92-93.
  142. Epstein JB, van der Meij EH, Emerton SM, Le ND, Stevenson-Moore, P. Compliance with fluoride gel use in irradiated patients. Spec Care Dentist 1995; 15 (6): 218-222.
  143. Epstein JB, Ransier A, Lunn R, Chin E, Jacobson J, Le N, Reece D. Prophylaxis of candidiasis in leukemia and bone marrow transplant patients. Oral Surg Oral Med Oral Pathol Endod 1996; 81: 291-296.
  144. Epstein JB, Grushka M. Recognition of medically necessary oral health care. J Can Dent Assoc 1996; 62: 15-16.
  145. Kolbinson DA, Epstein JB, Burgess JA. Temporomandibular Disorders, Headaches, and Neck Pain Following Motor Vehicle Accidents and the Effect of Litigation: Review of the Literature. J Orofacial Pain 1996; 10: 101-125.
  146. Epstein, JB. Discussion: Intralesional vinblastine injections for the treatment of oral Kaposi’s sarcoma: report of 10 patients with 2-Year follow-up. J Oral Maxillofac Surg 1996; 54: 588-589.
  147. van der Meij, EH, Epstein, JB, Hay, J, Ho, V, Lerner, K. Sweet’s syndrome in a patient with oral cancer associated with radiotherapy. Eur J Cancer Oral Oncol 1996; 32B (2): 133-136.
  148. Epstein JB, Ransier A, Sherlock CH, Spinelli JJ, Reece D. Acyclovir prophylaxis of oral Herpes virus during bone marrow transplantation.  Eur J Cancer Oral Oncol 1996; 32B (3): 158-62.
  149. Epstein JB, Waisglass M, Bhimji S, Le N, Stevenson-Moore P. A comparison of computed tomography and panoramic radiography in assessing malignancy of the maxillary antrum. Eur J Cancer Oral Oncol 1996; 32B (3): 191-201.
  150. Epstein JB. Book Review: Porter S, Scully C. Oral health care for those with HIV infection and other special needs. Eur J Cancer Oral Oncol 1996; 32B (3): 215.
  151. Epstein JB, Rea G, Sherlock CH, Mathias RG. Continuing investigation and controversy regarding risk of transmission of infection via dental handpieces. J Canada Dent Assoc 1996; 62 (6): 485-491.
  152. Rishiraj B, Epstein J.  Smokeless tobacco.  Family Health 1996; 12 (3): 27.
  153. Epstein JB, van der Meij EH, Lunn R, Le ND, Stevenson-Moore P. Effects of compliance with fluoride gel application on caries and caries risk in patients after radiation therapy for head and neck cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996; 82: 268-75.
  154. Scully C, Epstein JB.  Oral health care for the cancer patient.  Eur J Cancer Oral Oncol 1996; 32(B): 281-92.
  155. Epstein JB, McCarthy GM.  Progress in HIV and AIDS care.  J Canada Dent Assoc 1996; 62: 866-7.
  156. Epstein JB, Truelove EL.  Topical cyclosporine in a bioadhesive for treatment of oral lichenoid mucosal reactions: an open label clinical trial.  Oral Surg Oral Med Oral Pathol 1996; 82 (5): 532-6.
  157. Burgess JA, Kolbinson D, Lee P, Epstein JB.  Motor vehicle accidents and TMDS: assessing the relationship.  J Am Dent Assoc 1996; 127: 1767-72.
  158. Epstein JB.  Oropharyngeal candidiasis in the immunocompetent host.  J Mycol Med 1996; 6 (Suppl. II): 31-41.
  159. Epstein J, van der Meij E, McKenzie M, Wong F, Stevenson-Moore P. Hyperbaric oxygen therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endodont 1996;81(3):265-6.
  160. Kolbinson D, Epstein JB, Burgess J, Senthilselvan A.  Temporomandibular disorders, headaches, and neck pain after motor vehicle accidents: A pilot investigation of persistence and litigation effects.  J Prosthet Dent 1997; 77: 46-53.
  161. Epstein JB, Ship J. Increased emphasis of medically necessary oral health care.  Oral Surg Oral Med Oral Pathol 1997; 83: 307.
  162. Roy A, Epstein JB, Onno E.  Latex allergies in dentistry: recognition and recommendations.  J Canada Dent Assoc 1997; 63 (4): 297-300.
  163. Wiebe C, Epstein JB. An atlas of HIV-associated oral lesions: A new classification and diagnostic criteria.  J Canada Dent Assoc 1997; 63: 288-294.
  164. Munk PL, Morgan-Parkes J, Lee MJ, Janzen DL, Poon PY, Logan PM, Connell DG, Epstein JB, Tsang V.  Introduction to panoramic dental radiography in oncologic practice.  Am J Radiol 1997; 168: 939-943.
  165. Epstein JB, Oakley C, Millner A, Emerton S, van der Meij E, Le N.  The utility of toluidine blue application as a diagnostic aid in patients previously treated for upper oropharyngeal carcinoma.  Oral Surg Oral Med Oral Pathol 1997; 83 (5): 537-547.
  166. Epstein JB, van der Meij E.  Complicating mucosal reactions in patients receiving radiation therapy for head and neck cancer.  Spec Care Dentist 1997; 17 (3): 88-93.
  167. Epstein J, van der Meij E, McKenzie M, Wong F, Lepawsky M, Stevenson-Moore P.  Postradiation osteonecrosis of the mandible.  A long-term follow-up study.  Oral Surg Oral Med Oral Pathol 1997; 83 (6): 657-662.
  168. Kolbinson D, Epstein JB, Senthilselvan A, Burgess J.  A comparison of TMD patients with or without prior motor vehicle accident involvement: Initial signs, symptoms and diagnostic characteristics.  J Orofac Pain 1997; 11: 206-214.
  169. Epstein JB.  Management of oral Kaposi’s sarcoma and a proposal for clinical staging.  Oral Diseases 1997; 3: S124-S128.
  170. Epstein JB, Emerton S, Guglietta A, Le N.  Assessment of epidermal growth factor in oral secretions of patients receiving radiation therapy for cancer.  Oral Oncology 1997; 33: 359-363.
  171. Epstein JB.  Radiographic manifestations of multiple myeloma in the mandible: A retrospective study of 77 patients. (Discussion) J Oral Maxillofac Surg 1997; 55: 454-455.
  172. Oakley C, Epstein JB, Sherlock CH.  Reactivation of oral herpes simplex virus. Implications for clinical management of herpes simplex virus recurrence during radiotherapy.  Oral Surg Oral Med Oral Pathol 1997; 84: 272-278.
  173. Epstein JB, Grushka M, Le N.  Topical clonidine for orofacial pain: a pilot study.  J Orofacial Pain 1997; 11 (4): 346-352.
  174. Kolbinson D, Epstein JB, Senthilselvan A, Burgess J.  A comparison of TMD patients with or without prior motor vehicle accident involvement: treatment and outcomes.  J Orofacial Pain 1997; 11 (4): 337-345.
  175. Epstein JB, Scully C.  Assessing the patient at risk for oral squamous cell carcinoma.  Spec Care Dentist 1997; 17 (4): 120-128.
  176. Rosin MP, Epstein JB, Berean K, Durham S, Hay J, Cheng X, Zeng T, Huang Y, Zhang L.  The use of exfoliative cell samples to map clonal genetic alterations in the oral epithelium of high-risk patients. Cancer Res 1997; 57 (23): 5258-5260.
  177. Epstein, JB.  How do we know something works?  Truth or consequences.  Spec Care Dentist 1997; 17 (6): 89-90.
  178. Epstein JB, Polsky B. Oropharyngeal candidiasis: a review of its clinical spectrum and current therapies.  Clin Therapeutics 1998; 20: 40-57.
  179. Gorsky M, Epstein JB.  Head and neck and intra-oral soft tissue sarcomas. Oral Oncology 1998; 34: 292-6.
  180. Kolbinson DA, Epstein JB, Ambikaipakan S, Burgess JA.  Effect of impact and injury characteristics on post-motor vehicle accident temporomandibular disorders.  Oral Surg Oral Med Oral Pathol Oral Radiol  Endod 1998; 85 (6): 665-73.
  181. Epstein JB.  Infective endocarditis: Dental implications and new guidelines for antibiotic prophylaxis.  J Canada Dent Assoc 1998; 64 (4): 281-92.
  182. Epstein JB, Silverman S Jr, Gorsky M.  The continuing epidemic of HIV and Aids in 1998.  J Canada Dent Assoc 1998; 64 (6): 426-30.
  183. Epstein JB, Gorsky M, Wong FLW, Millner A.  Topical bleomycin for the treatment of dysplastic oral leukoplakia.  Cancer 1998; 83 (4): 629-34.
  184. Haas DA, Epstein JB, Eggert FM.  Antimicrobial resistance: dentistry’s role.  J Canada Dent Assoc 1998; 64 (7): 496-503.
  185. Epstein JB, Chin EA, Jacobson JJ, Rishiraj B, Le N.  The relationships among fluoride, cariogenic oral flora, and salivary flow rate during radiation therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 86 (3): 286-292.
  186. Grushka M, Epstein J, Mott A.  An open-label, dose escalation pilot study of the effect of clonazepam in burning mouth syndrome.  Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 86 (5): 557-561.
  187. Epstein JB, Lunn R, Le N, Stevenson-Moore P.  Periodontal attachment loss in patients after head and neck radiation therapy.  Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 86 (6): 673-677.
  188. Gorsky M, Epstein JB.  Melanoma arising from the mucosal surfaces of the head and neck.  Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 86 (6): 715-719.
  189. Warnakulasuriya ME, Speight P, Epstein JB. Diagnosing oral cancer: Can toluidine blue mouthwash help? FDI World 1998; 7(2):22-26.
  190. Epstein JB, Emerton S, Lunn R, Le N, Wong FLW.  Pretreatment assessment and dental management of patients with nasopharyngeal carcinoma. Oral Oncology 1999; 35 (1): 33-39.
  191. Epstein JB, Emerton S, Kolbinson D, Le N, Phillips N, Stevenson-Moore P, Osoba D. Quality of life and oral function following radiotherapy for head and neck cancer. Head and Neck 1999; 21(1): 1-11.
  192. Epstein JB. Infective Endocarditis and Dentistry: Outcome-based Research. J Canada Dent Assoc 1999; 65(2): 95-96.
  193. Rishiraj B, Epstein JB. Basal cell carcinoma: what dentists need to know. J Am Dent Assoc 1999;130:375-380.
  194. Epstein JB, Emerton S, Le ND, Stevenson-Moore P. A double-blind crossover trial of Oral Balance gel and Biotene toothpaste versus placebo in patients with xerostomia following radiation therapy. Oral Oncology 1999; 35(2): 132-137.
  195. Scully C, Porter SR, Mutlu S, Epstein JB, Glover S, Kumar N. Periodontopathic bacteria in English HIV-seropositive persons. AIDS Patient Care and STDs 1999;13(6):369-374.
  196. Onno EM, Epstein J. How to manage the latex allergic patient. Connections. Newsletter of the Association of Dental Surgeons of British Columbia 1999(May);10.
  197. Sonis ST, Eilers JP, Epstein JB, LeVeque FG, Liggett WH Jr, Mulagha MT, Peterson DE, Rose AH, Schubert MM, Spijkervet FK, Wittes JP. Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Cancer 1999; 85(10): 2103-2113.
  198. Epstein JB, Schubert MM. Oral mucositis in myelosuppressive cancer therapy. Oral Surg Oral Med Oral Pathol 1999; 88(3): 273-276.
  199. Epstein JB, Gorsky M. Topical application of vitamin A to oral leukoplakia: a clinical case series. Cancer 1999; 86(6): 921-927.
  200. Zhang L, Epstein J, Band P, Berean K, Hay J, Cheng X, Rosin MP. Local tumor recurrence or emergence of a new primary lesion? A molecular analysis. J Oral Path Med. 1999;28(8):381-384.
  201. Epstein JB, Chow AW. Oral complications associated with immunosuppression and cancer therapies. Infectious Disease Clinics of North America. 1999;13(4):901-923.
  202. Bellm LA, Epstein JB, Rose-Ped A, Martin P, Fuchs HJ. Patient reports of complications of bone marrow transplantation. Supp Care Cancer. 2000; 8:33-39.
  203. Gorsky M, Epstein JB. Craniofacial osseous and chondromatous sarcomas in British Columbia – a review of 34 cases. Oral Oncology 2000; 36:27-31.
  204. Rosin MP, Cheng X, Poh C, Lam WL, Huang Y, Lovas J, Berean K, Epstein JB, Priddy R, Le ND, Zhang L. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clinical Cancer Research. 2000;6(2):357-362.
  205. Walsh PM, Epstein JB. The oral effects of smokeless tobacco. J Canada Dent Assoc. 2000;66(1):22-25.
  206. Epstein JB. Facilitating Clinical Oral Research in Canada. J Canada Dent Assoc. 2000;66:140-141.
  207. Epstein JB, Nantel S, Shoeltch SM. Topical azathioprine in the combined treatment of chronic oral graft-versus-host disease. Bone Marrow Transplant 2000;25:683-687.
  208. Hamidi S, Salo T, Kainulainen T, Epstein J, Lerner K, Larjava H. Expression of avb6 integrin in oral leukoplakia. Brit J Cancer. 2000;82(8):1433-1440.
  209. Grushka M, Kawalec J, Epstein JB. Burning mouth syndrome: Evolving concepts. Oral Maxillofac Surg Clin N Am 2000;12:287-95.
  210. Mackie AM, Epstein JB, Wu JSY, Stevenson-Moore P. Nasopharyngeal carcinoma: the role of the dentist in assessment, early diagnosis and care before and after cancer therapy. Oral Oncology 2000; 36:397-403.
  211. Epstein JB. Osteoradionecrosis of the jaws: clinical characteristics and relation to the field of irradiation. J Oral Maxillofacial Surg 2000;58:1093-5.
  212. Hildebrand HC, Epstein J, Larjava H. The influence of psychological stress on periodontal disease. J West Soc Periodontol-Periodontal Abst 2000;48:69-77.
  213. Epstein JB, Chong S, Le ND. A survey of antibiotic use in dentistry. J Am Dent Assoc 2000;131:1600-9.
  214. Epstein JB, Tejani A, Glassman P. Assessment of objectives of post-doctoral general dentistry programs in dentistry.  Spec Care Dent 2000;20:191-4.
  215. Gorsky M, Epstein JB. A case series of acquired immunodeficiency syndrome patients with initial neoplastic diagnoses of intraoral Kaposi's sarcoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;90:612-7.
  216. Goldstein BH, Epstein JB. Unconventional dentistry: Part IV: Unconventional dental practices and products. J Canada Dent Assoc 2000;66:564-8.
  217. Epstein JB, Gorsky M, Guglietta A, Le N, Sonis ST. The correlation between epidermal growth factor levels in saliva and severity of oral mucositis during oropharyngeal radiation therapy.  Cancer 2000;89:2258-65.
  218. Chou LL, Epstein J, Cassol SA, West DM, He W, Firth JD. Oral mucosal Langerhans’ cells as target, effector and vector in HIV infection. J Oral Pathol Med 2000;29:394-402.
  219. Bellm LA, Epstein JB, Rose-Ped AM, Fu R, Martin PJ, Fuchs HJ. Assessment of various topical oral formulations by bone marrow transplant recipients. Oral Oncology 2001;37:42-9.
  220. Miller CS, Epstein JB, Hall EH, Sirois D. Changing oral care needs in the United States: The continuing need for oral medicine. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;91:34-44.
  221. Epstein JB, Gorsky M, Epstein MS, Nantel S. Topical azathioprine in the treatment of immune-mediated chronic inflammatory conditions: A series of cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;91:56-61.
  222. Poh CF, Zhang L, Lam WL, Zhang X, An D, Chau C, Priddy R, Epstein JB, Rosin MP. A high frequency of allelic loss in oral verrucous lesions may explain malignant risk. Lab Invest 2001;81:629-34.
  223. Sonis ST, Oster G, Fuchs H, Bellm L, Bradford WZ, Edelsberg J, Hayden V, Eilers J, Epstein JB, LeVeque FG, Miller C, Peterson DE, Schubert MM, Spijkervet FK, Horowitz M.  Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation.
    J Clin Oncol. 2001;19(8):2201-5.
  224. Epstein JB, Robertson M, Emerton S, Phillips N, Stevenson-Moore P. Quality of life and oral function in patients treated with radiation therapy for head and neck cancer. Head Neck 2001;23(5):389-98.
  225. Zhang L, Poh CF, Lam WL, Epstein JB, Cheng X, Zhang X, Priddy R, Lovas J, Le ND, Rosin MP.  Impact of localized treatment in reducing risk of progression of low-grade oral dysplasia: molecular evidence of incomplete resection.  Oral Oncology 2001, 37: 505-512.
  226. Zhang L, Cheung KJ Jr, Lam WL, Cheng X, Poh C, Priddy R, Epstein J, Le ND, Rosin MP. Increased genetic damage in oral leukoplakia from high risk sites: potential impact on staging and clinical management.  Cancer 2001, 91: 2148-55.
  227. Epstein JB, Caldwell J, Black G. The utility of panoramic imaging of the temporomandibular joint in patients with temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;92:236-9.
  228. Epstein JB, Silverman S Jr, Paggiarino DA, Crocket S, Schubert MM, Senzer NN, Lockhart PB, Gallagher MJ, Peterson De, Leveque FG.  Benzydamine HCl for prophylaxis of radiation-induced oral mucositis: results from a multicenter, randomized, doubleblind, placebo-controlled clinical trial. Cancer 2001;92:875-85.
  229. Epstein JB, Stevenson-Moore P. Periodontal disease and periodontal management in patients with cancer. Oral Oncology 2001;37:613-9.
  230. Epstein JB, Truelove EL, Oien H, Allison C, Le ND, Epstein MS. Oral topical doxepin rinse: analgesic effect in patients with oral mucosal pain due to cancer or cancer therapy. Oral Oncology 2001; 37:632-7.
  231. May N, Epstein J, Osborne B. Selective COX-2 inhibitors: A review of their therapeutic potential and safety in dentistry. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;92:399-405.
  232. Drangsholt M, Truelove EL, Morton TH, Epstein JB. Evidence-based case conference: A man with a 30-year history of oral lesions. J Evidence Based Dent Pract 2001;1:123-35.
  233. Epstein JB, Epstein JD, Le ND, Gorsky M. Characteristics of oral and paraoral malignant lymphoma: a population-based review of 361 cases. Oral Surg Oral Med Oral Pathol Radiol Endod 2001;92:519-25.
  234. Comeau TB, Epstein JB, Migas C. Taste and smell dysfunction in patients receiving chemotherapy: a review of current knowledge. Support Care Cancer 2001;9:575-80.
  235. Jacobsen PL, Epstein JB, Cohan RP. Understanding "alternative" dental products. Gen Dent 2001;49:616-22.
  236. Bellm LA, Cunningham G, Durnell L, Eilers J, Epstein JB, Fleming T, Fuchs HJ, Haskins MN, Horowitz MM, Martin PJ, McGuire DB, Mullane K, Oster G. Defining clinically meaningful outcomes in the evaluation of new treatments for oral mucositis. Oral Mucositis Patient Provider Advisory Board. Cancer Invest 2002;20:1-8.
  237. Grushka M, Epstein J, Gorsky M. Burning Mouth Syndrome. Am Fam Phys 2002;65:615-22.
  238. Zhang L, Epstein JB, Poh CF, Berean K, Lam WL, Zhang X, Rosin MP.  Comparison of HPV, p53 mutation and allelic losses in post-transplant and non-post-transplant oral squamous cell carcinomas.  J Oral Path Med 2002, 31(3): 134-141.
  239. Epstein JB, Rea A, Chahal O. The use of bone scintigraphy in temporomandibular joint disorders. Oral Diseases 2002;8:47-53.
  240. Epstein JB, Gorsky M, Caldwell J. Fluconazole mouthrinses for oral candidiasis in postirradiation, transplant, and other patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;93:671-5.
  241. Tejani A, Epstein JB, Gibson G, Le N. A survey assessing the impact of a hospital-based General Practice Residency Program on dentists and dental practice. Spec Care Dentist 2002;22:16-22.
  242. Gorsky M, Epstein JB. The effect of retinoids on premalignant oral lesions: focus on topical therapy. Cancer 2002;95:1258-64.
  243. El-Sayed S, Epstein J, Minish E, Burns P, Hay J, Laukkanen E. A pilot study evaluating the safety and microbiologic efficacy of an economically viable antimicrobial lozenge in patients with head and neck cancer receiving radiation therapy. Head Neck 2002;24:6-15.
  244. Lodi G, Bez C, Porter SR, Epstein JB. Infectious hepatitis C, hepatitis G, and TT viruses: review and implications for dentists. Special Care Dent 2002; 22:53-8.
  245. Cramer CK, Epstein JB, Sheps SB, Schechter MT, Busser JR.  Modified delphi survey for decision analysis for prophylaxis of post-radiation osteonecrosis.  Oral Oncology 2002;38:574-83.
  246. Warkentin DI, Epstein JB, Campbell LM, Yip JG, Cox VC, Ransier A, Barnett MJ, Marra F. Valacyclovir versus acyclovir for HSV prophylaxis in neutropenic patients. Ann Pharmacother 2002;36:1525-31.
  247. Epstein JB, Tsang AH, Warkentin D, Ship JA. The role of salivary function in modulating chemotherapy-induced oropharyngeal mucositis: a review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;94:39-44.
  248. Raber-Durlacher JE, Epstein JB, Raber J, van Dissel JT, van Winkelhoff AZ, Guiot HF, van der Velden U. Periodontal infection in cancer patients treated with high-dose chemotherapy. Supportive Care Cancer 2002;10:466-73.
  249. Epstein JB, Zhang L, Rosin M. Advances in the diagnosis of oral premalignant and malignant lesions. J Canada Dent Assoc 2002;68:617-21.
  250. Epstein JB, Dawson JR, Wong B, Le ND. The effect of a disinfectant/coolant irrigant on microbes isolated from dental unit water lines. Spec Care Dentist 2002;22:137-41.
  251. Rose-Ped AM, Bellm LA, Epstein JB, Trotti A, Gwede C, Fuchs HJ. Complications of radiation therapy for head and neck cancers: The patient’s perspective. Cancer Nursing 2002:25:461-467.
  252. Grushka M, Epstein JB, Gorksy M. The changing face of orofacial pain: Burning mouth syndrome and links to other oral sensory pains. Ontario Dentist 2002; 79:14-17.
  253. Grushka M, Epstein JB, Gorksy M. Temporomandibular disorder (TMD) associated with a whiplash injury differs from TMD without trauma.  Ontario Dentist 2002; 79:18-21.
  254. Epstein JB, O’Keefe J.  Point of Care: Can I extract teeth after a patient has undergone radiation therapy? J Canada Dent Assoc 2002;68:636-7.
  255. Epstein JB, Gorsky M, Hancock P, Peters N, Sherlock CH. The prevalence of herpes simplex virus shedding and infection in the oral cavity of seropositive patients undergoing head and neck radiation therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;94:712-6.
  256. Grushka M, Epstein JB, Gorsky M. Burning mouth syndrome: Differential diagnosis. Dermatologic Therapy 2002;15:287-91.
  257. Epstein JB, Phillips N, Parry J, Epstein MS, Nevill T, Stevenson-Moore P. Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2002;30:785-92.
  258. El-Sayed S, Babid A, Shelley W, Hay J, Balogh J, Gelinas M, MacKenzie R, Read N, Berthelet E, Lau H, Epstein J, Delvecchio P, Ganguly PK, Wong F, Burns P, Tu D, Pater J. Prophylaxis of radiation-associated mucositis in conventionally treated patients with head and neck cancer: a double-blind, phase III, randomized, controlled trial evaluating the clinical efficacy of an antimicrobial lozenge using a validated mucositis scoring system. J Clin Oncol 2002;20:3956-63.
  259. Sadler GR, Stoudt A, Fullerton JT, Oberle-Edwards LK, Nguyen Q, Epstein JB. Managing the oral sequelae of cancer therapy.  MedSurg Nursing 2003;12:28-36.
  260. Epstein JB. Diagnosis and treatment of oropharyngeal candidiasis. Oral Maxillofacial Surg Clin N Am 2003; 15:91-102.
  261. Kuo WP, Whipple ME, Jenssen T-K, Todd R, Epstein JB, Ohno-Machado L, Sonis ST, Park PJ. Microarrays and clinical dentistry. J Am Dent Assoc 2003;134:456-62.
  262. Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK, Komaroff E, Nalysynk L, Zilberberg MD. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiotherapy Oncology 2003;66:253-62.
  263. Epstein JB, Zhang L, Poh C, Nakamura H, Berean K, Rosin M. Increased allelic loss in toluidine blue-positive oral premalignant lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 95:45-50.
  264. Mohan S, Epstein JB. Carcinogenesis and cyclooxygenase: the potential role of COX-2 inhibition in upper aerodigestive tract cancer. Oral Oncology 2003; 39(6):537-46.
  265. Donnelly JP, Bellm LA, Epstein JB, Sonis ST, Symonds RP. Antimicrobial therapy to prevent or treat oral mucositis. Lancet Infect Dis 2003;3:405-12.
  266. Epstein JB, Wan LS, Gorsky M, Zhang L. Oral lichen planus: progress in understanding its malignant potential and the implications for clinical management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;96:32-7.
  267. Epstein JB, Hancock PJ, Nantel S. Oral candidiasis in hematopoietic cell transplantation patients: an outcome-based analysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;96:154-63.
  268. Hancock PJ, Epstein JB, Sadler GR. Oral and dental management related to radiation therapy for head and neck cancer. J Canada Dent Assoc 2003;69:585-90.
  269. Gu G-M, Epstein JB, Morton TH. Intra-oral melanoma: Long-term follow-up and implications for dental clinicians. A case report and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;96:404-13.
  270. Epstein JB, Feldman R, Dolor RJ, Porter SR. The utility of tolonium chloride rinse in the diagnosis of recurrent or second primary cancers in patients with prior upper aerodigestive tract cancer.  Head and Neck 2003;25:911-21.
  271. Grushka M, Epstein JB, Gorsky M. Burning mouth syndrome and other oral sensory disorders: A unifying hypothesis. Pain Research Management 2003;8:133-5.
  272. Epstein JB, Schubert MM. Oropharyngeal mucositis in cancer therapy: Review of pathogenesis, diagnosis and management. Oncology 2003;17:1767-79.
  273. Epstein JB, Truelove EL, Oien H, Le ND, Epstein MS.  Oral topical doxepin rinse: anesthetic effect in normal subjects. Pain Res Manag. 2003;8:195-7.
  274. Epstein J. Current developments in treating chemotherapy related oral mucositis. Clin Advance Hematol Oncol 2003;12:712-3.
  275. Scully C. Epstein J. Sonis S. Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy: Part 1, Pathogenesis and prophylaxis of mucositis. Head and Neck 2003;25:1057-70.
  276. Fischer DJ, Epstein JB, Morton TH, Schwartz SM. Inter-observer reliability in the histopathologic diagnosis of oral premalignant and malignant lesions. J Oral Pathol Med 2004;33:65-70.
  277. Sonis ST, O’Donnell KE, Popat R, Bragdon C, Phelan S, Cocks D, Epstein JB. The relationship between mucosal cyclooxygenase-2 (COX-2) expression and experimental radiation-induced mucositis. Oral Oncol 2004;40:170-6.
  278. Gorsky M, Epstein JB, Parry J, Epstein MS, Le ND, Silverman S Jr. The efficacy of pilocarpine and bethanechol upon saliva production in cancer patients with hyposalivation following radiation therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;97:190-5.
  279. Eilers J, Epstein JB. Assessment and measurement of oral mucositis. Sem Oncol Nurs 2004;20:22-29.
  280. Epstein JB, Schubert MM. Managing pain in mucositis. Sem Oncol Nurs 2004;20:30-37.
  281. Barasch A, Epstein JB, Foong WC, Clayman L. Intralesional chemotherapy for head and neck carcinoma: A review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;97:307-11.
  282. Epstein JB, Wigdor H. Oropharyngeal cancer and oral complications of cancer therapy: considerations in older patients. Geriatrics and Aging 2004;7: 59-64.
  283. Kuo WP, Whipple ME, Epstein JB, Jenssen T-K, Santos GS, Ohno-Machado L, Sonis ST.  Deciphering gene expression profiles generated from DNA microarrays and their applications in oral medicine. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;97:584-91.
  284. Gorsky M, Epstein JB, Hasson-Kanfi H, Kaufman E.  Smoking habits among patients diagnosed with oral lichen plans. Tobacco Induced Disease 2004;2:103-8.
  285. Rubenstein EB. Peterson DE. Schubert M. Keefe D. McGuire D. Epstein J. Elting LS. Fox PC. Cooksley C. Sonis ST. Mucositis Study Section of the Multinational Association for Supportive Care in Cancer. International Society for Oral Oncology. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 2004;100 (suppl 1):2026-46.
  286. Scully C. Epstein J. Sonis S. Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy. Part 2: diagnosis and management of mucositis. Head and Neck 2004;26:77-84.
  287. Ransier A, Epstein JB, Kauffman E, Gorsky M. Use of chlorhexidine oral rinse in patients receiving hematopoietic cell transplants. J Appl Res Clin Dent 2004;1:1-6.
  288. Epstein JB, Grushka M. Point of Care: What can I do to assess a patient with burning mouth syndrome. J Canada Dent Assoc 2004;70:634-5.
  289. Epstein JB. Parker IR. Epstein MS. Stevenson-Moore P. Cancer-related oral health care services and resources: a survey of oral and dental care in Canadian cancer centres. J Canada Dent Assoc 2004;70(5):302-4.
  290. Epstein JB, Hollender L, Pruzan SR. Mucoepidermioid carcinoma in a young adult: Recognition, diagnosis and treatment and responsibility. Gen Dentistry 2004;52:434-40.
  291. Epstein JB. Truelove EL. Hanson-Huggins K. Mancl LA. Chen A. Press OW. Petersdorf SH. Fritsche TR. Epstein JD. Topical polyene antifungals in hematopoietic cell transplant patients: tolerability and efficacy.  Support Care Cancer 2004;12(7):517-25.
  292. Golla K, Epstein JB, Cabay RJ. Liver disease: Current perspectives on medical and dental management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004; 98:516-21.
  293. Gorsky M, Epstein JB, Oakley C, Le ND, Hay J, Stevenson-Moore P.  Carcinoma of the tongue: a case series analysis of clinical presentation, risk factors, staging, and outcome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004; 98:546-52.
  294. Golla K, Epstein JB, Rada RE, Sanai R, Messieha Z, Cabay RJ. Diabetes mellitus: An updated overview of medical management and dental implications. General  Dentistry 2004;52:529-36
  295. Epstein JB. Burning mouth syndrome: how to put out the fire. Consultant: Peer-Reviewed Consultations in Primary Care 2004; 44:1611.
  296. Gu G-M, Martin MD, Darveau RP, Truelove E, Epstein J. Oral and serum IL-6 levels in oral lichen planus patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;98:673-8.
  297. Epstein JB, Raber-Durlacher JE. Topical agents for the management of oral complications in cancer patients. Business Briefing: US Oncology Rev 2004;83-84;999-1004.
  298. Esmeili T, Lozada-Nur F, Epstein J. Common benign oral soft tissue masses. Dent Clin N Am 2005;49(1):223-40.
  299. Barker GJ, Epstein JB, Williams KB, Gorsky M, Raber-Durlacher JE. Current practice and knowledge of oral care for cancer patients: a survey of supportive health care providers. Support Care Cancer 2005;13:32-41.
  300. Rishiraj B, Epstein JB, Fine D, Nabi S, Wade NK. Permanent vision loss in one eye following administration of local anesthesia for a dental extraction. Int J Oral Maxillofac Surg 2005;34(2):220-3.
  301. Epstein JB, Lunn R, Le ND, Stevenson-Moore P, Gorsky M. Patients with oropharyngeal cancer: a comparison of adults living independently and patients living in long-term care facilities. Spec Care Dentist 2005;25(2):124-30.
  302. Kaufman E, Epstein JB, Gorsky M, Jackson DL, Kadari A. Preemptive analgesia and local anesthesia as a supplement to general anesthesia: A review. Anesth Prog 2005;52(1):29-38.
  303. Duncan GG, Epstein JB, Tu D, Sayed SE, Bezjak A, Ottaway J, Pater J. Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: A report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis. Head and Neck. 2005;27(5):421-8.
  304. Fischer DJ, Epstein JB, Morton TH, Schwartz SM. Reliability of histologic diagnosis of clinically normal intraoral tissue adjacent to clinically suspicious lesions in former upper aerodigestive tract cancer patients Oral Oncol 2005; 41;(5):489-496
  305. Modi BJ, Knab B, Feldman LE, Mundt AJ, Yao M, Pytynia KB, Epstein J. Review of current treatment practices for carcinoma of the head and neck. Expert Opin Pharmacother 2005;6(7):1143-55
  306. Zhang L, Williams M, Poh CF, Laronde D, Epstein J, Durham S, Nakamura H, Berean K, Hovan A, Le N, Hislop G, Priddy R, Hay J, Lam W, Rosin MP.  Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome.  Cancer Res, 2005:1;65(17):8017-21.
  307. Klasser GD, Epstein J. Nonsteroidal anti-inflammatory drugs: confusion, controversy and dental implications. J Canada Dent Assoc. 2005 Sep;71(8):575-80
  308. Epstein JB, Klasser GD, Migliorati C. What can I do for a patient who is taking bisphosphonates and who has an area of exposed bone in the oral cavity that will not heal? J Canada Dent Assoc 2005;Oct; 71(9);638-9.
  309. Klasser GD, Epstein JB. Why do some patients complain of a toothache long after a successful endodontic procedure?  J Canada Dent Assoc 2005;71(9);640-1.
  310. Epstein JB, Cabay RJ, Glick M. Oral malignancies in HIV disease: Changes in disease presentation, increasing understanding of molecular pathogenesis, and current management.  Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005;100(5):551-8.
  311. Raber-Durlacher JE, Epstein JB, Bresters D, Stern-Zivan L. Oral complications in children with cancer. Clinical practice. Supplement to the European Journal of Paediatric Dentistry, 2005(6): 3-12.
  312. Migliorati CA, Casiglia J, Epstein J, Jacobsen PL, Siegel MA, Woo S-B. Managing the care of patients with bisphosphonate-associated osteonecrosis: An American Academy of Oral Medicine position paper. J Am Dent Assoc 2005(12);136:1658-68.
  313. Klasser GD, Epstein J. Methamphetamine and its impact on dental care. J Canada Dent Assoc 2005;71(10):759-62.
  314. Kaufman E, Epstein JB, Naveh E, Gorsky M, Gross A, Cohen G. A survey of pain, pressure, and discomfort induced by commonly used oral local anesthesia injections. Anesth Prog 2005;52(4):122-7.
  315. Epstein JB, Klasser GD. Emerging approaches for prophylaxis and management of oropharyngeal mucositis in cancer therapy. Expert Opinion Emerging Drugs 2006;11(2):353-73.
  316. Barasch A, Elad S, Altman A, Damato K, Epstein J. Antimicrobials, mucosal coating agents, anesthetics, analgesics, and nutritional supplements for alimentary tract mucositis. Support Care Cancer 2006;14(6):528-32.
  317. Sroussi HY, Villines D, Epstein J, Alves MCF, Alves MEAF.  The correlation between prevalence of oral manifestations of HIV and CD4+ lymphocyte counts weakens with time. J. Acquir Immune Defic Syndr 2006;42(4):516-8.
  318. Epstein JB, Epstein JD, Epstein MS, Oien H, Truelove EL. Oral doxepin rinse: the analgesic effect and duration of pain reduction inpatients with oral mucositis due to cancer therapy.  Anesth Analg 2006;103(2):465-70.
  319. Chainani-Wu N, Gorsky M, Mayer P, Bostrom A, Epstein JB, Silverman S Jr. Assessment of the use of sialogogues in the clinical management of patients with xerostomia. Spec Care Dent 2006;26(4):164-70.
  320. Epstein JB, Gorsky M, Lonky S, Silverman S Jr, Epstein JD, Bride M. The efficacy of oral lumenoscopyTM (ViziLite®) in visualizing oral mucosal lesions. Spec Care Dent 2006;26(4):171-4.
  321. Grushka M, Ching V, Epstein J. Burning mouth syndrome. Advances in Oto-Rhino-Laryngology 2006;63:278-87.
  322. Kerr AR, Sirois DA, Epstein JB. Clinical evaluation of chemiluminescent lighting: an adjunct for oral mucosal examinations. J Clin Dent 2006; 17:59-63.
  323. Klasser GD, Epstein JB. The methamphetamine epidemic and dentistry. Gen Dentistry 2006; 54(6):431-9.
  324. Yao M, Epstein JB, Modi BJ, Pytynia KB, Mundt AJ, Feldman LE. Current surgical treatment of squamous cell carcinoma of the head and neck. Oral Oncol 2007;43(3):213-23.
  325. Mehta SA, Epstein JB, Greene C. Recognition and management of headache. J Canada Dent Assoc 2006; 72(9):835-9.
  326. Gupta A, Epstein JB, Sroussi H. Hyposalivation in elderly patients. J Canada Dent Assoc 2006;72(9):841-6.
  327. Gupta A, Epstein JB, Cabay RJ. Bleeding disorders of importance in dental care and related patient management. J Canada Dent Assoc 2007;73(1):77-83.
  328. Itthagarun A, Nair RG, Epstein JB, King NM. Fetal alcohol syndrome: case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103(3):e20-5.
  329. Epstein JB, Parker IR, Epstein MS, Gupta A, Kutis S, Witkowski DM. A survey of National Cancer Institute-designated comprehensive cancer centers’ oral health supportive care practices and resources in the USA. Support Care Cancer 2007; 15:357-62.
  330. Brennan M, Migliorati CA, Lockhart PB, Wray D, Al-Hashimi I, Axell T, Bruce AJ, Carpenter W, Eisenberg E, Epstein JB, Holmstrup P, Jontell M, Nair R, Sasser H, Schifter M, Silverman SB, Thongprasom K, Thornhill M, Warnakulasuriya S, van der Waal I. Management of oral epithelial dysplasia: a review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103(Suppl 1): 19-24.
  331. Al-Hashimi I, Schifter M, Lockhart PB, Wray D, Brennan M, Migliorati CA, Axell T, Bruce AJ, Carpenter W, Eisenberg E, Epstein JB, Holmstrup P, Jontell M, Lozada-Nur F, Nair R, Silverman B, Thongprasom K, Thornhill M, Warnakulasuriya S, van der Waal I. Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103(Suppl 1):25-31.
  332. Epstein JB, Epstein JD, Epstein MS, Oien H, Truelove EL. Management of pain in cancer patients with oral mucositis: follow-up of multiple doses of doxepin oral rinse. J Pain Symptom Manage 2007;33(2):111-4.
  333. Gorsky M, Epstein, JB, Rabenstein, Sl, Elishoov, H, Yarom, N.  Topical minocycline and tetracycline rinses in treatment of recurrent aphthous stomatitis:  a randomized cross-over study.  Dermatology Online Journal 2007; 13 (2): 1.
  334. Keefe DM, Schubert MM, Elting LS, Sonis St, Epstein JB, Raber-Durlacher JE, Migliorati CA, McGuire DB, Hutchins RD, Peterson DE. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 2007;109(5):820-31.
  335. Gupta A, Epstein JB, Cabay RJ. Bleeding disorders of importance in dental care and related patient management. J Canada Dent Assoc 2007; 73(1):77-83.
  336. Epstein JB, Beaumont JL, Gwede CK, Murphy B. Garden AS, Meredith R, Le QT, Brizel D, Isitt J, Cella D.  Longitudinal evaluation of the oral mucositis weekly questionnaire-head and neck cancer, a patient-reported outcomes questionnaire.  Cancer. 2007;109(9):1914-22.
  337. Morton TH, Cabay RJ, Epstein JB.  Proliferative verrucous leukoplakia and its progression to oral carcinoma: report of three cases.  J Oral Pathol Med. 2007 May;36(5):315-8.
  338. Cabay RJ, Morton TH, Epstein JB.  Proliferative verrucous leukoplakia and its progression to oral carcinoma: a review of the literature.  J Oral Pathol Med. 2007 May;36(5):255-61.
  339. Wilder-Smith P, Hammer-Wilson MJ, Zhang J, Wang Q, Osann K, Chen Z, Widgor H, Schwartz J, Epstein J. In vivo imaging of oral mucositis in an animal model using optical coherence tomography and optical Doppler tomography. Clin Cancer Res 2007;13(8):2449-54.
  340. Sroussi HY, Villines D, Epstein J, Alves MCF, Alves MEAF. Oral lesion in HIV-positive dental patients-one more argument for tobacco smoking cessation. Oral Diseases 2007;13:324-8.
  341. Epstein JB, Wan L, Chrisman P, Dale BA, Jackson D.  Use of Mucosal fluid collection to assess oral mucositis in patients receiving head and neck radiation therapy: a feasibility study.  J Applied Res 2007;7(1): 50-57.
  342. Benoleil R, Epstein J, Eliav E, Jurevic R, Elad S. Orofacial pain in Cancer: Part I: Mechanisms. J Dent Res 2007; Jun;86(6):491-505
  343. Epstein JB, Elad S, Eliav E, Jurevic R, Benoliel R. Orofacial pain in cancer: Part II: Clinical perspectives and management. J Dent Res 2007; Jun;86(6):506-18.
  344. Epstein JB. AHA updates guidelines on preventing endocarditis. J Canada Dent Assoc 2007; June:73:380-1.
  345. Sroussi HY, Prabhu AR, Epstein JB. American Heart Association; British Society for Antimicrobial Chemotherapy; British Cardiac society: Which antibiotic prophylaxis guidelines for infective endocarditis should Canadian dentists follow? J Canada Dent Assoc 2007; Jun;73(5):401-5.
  346. Epstein JB. Mucositis in the cancer patient and the immunosuppressed host. Infect Dis Clin North Am 2007; Jun;21(2):503-22
  347. Epstein JB, Sciubba J, Silverman S Jr, Sroussi HY. Utility of toluidine blue in oral premalignant lesions and squamous cell carcinoma: Continuing research and implications for clinical practice. Head Neck. 2007; Oct;29(10):948-58.
  348. Grushka M, Ching VW, Epstein JB, Gorsky M. Radiographic and clinical features of temporomandibular dysfunction in patients following indirect trauma: A retrospective study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;104(6):772-80
  349. Klasser GD, Balasubramaniam R, Epstein J. Topical review-Connective tissue diseases: Orofacial manifestations including pain. J Orofac Pain 2007;21(3):171-84.
  350. Kawakami-Wong H, Gu S, Hammer-Wilson MJ, Epstein JB, Chen Z, Wilder-Smith P. In vivo optical coherence tomography-based scoring of oral mucositis in human subjects: a pilot study. J Biomed Opt  2007 Sept-Oct 12(5):051702.
  351. Epstein JB, Silverman S Jr, Epstein JD, Lonky SA, Bride MA. Analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue. Oral Oncol 2008;44: 538-44, 615.
  352. Epstein JB, Gorsky M, Fischer D, Gupta A, Epstein MS, Elad S. A survey of the current approaches to diagnosis and management of oral premalignant lesions. J Am Dent Assoc 2007;138(12):1555-62.
  353. Fischer DJ, Epstein JB. Management of patients who have undergone head and neck cancer treatment.  Dent Clin N Am 2008;52:39-60.
  354. Moswin AH, Epstein JB. Essential medical issues related to HIV in dentistry. J Canad Dent Assoc 2008;73(10):945-8.
  355. Sroussi HY, Epstein JB. Changes in the pattern of oral lesions associated with HIV infection: Implications for dentists. J Canad Dent Assoc 2008;73(10):949-52.
  356. Epstein JB. Oral malignancies associated with HIV. J Canad Dent Assoc 2008;73(10):953-6.
  357. Epstein JD, Knight TK, Epstein JB, Bride MA, Nichol MB. Cost of care for early- and late-stage oral and pharyngeal carcinoma. Head and Neck 2008;30(2):178-86.
  358. Epstein JB, Epstein JD, Epstein MS, Oien H, Truelove EL. Doxepin rinse for management of mucositis pain in patients with cancer: one week follow-up of topical therapy. Spec Care Dentist 2008;28(2):73-7.
  359. Gorsky M, Epstein J, Raviv A, Yaniv R, Truelove E. Topical minocycline for managing symptoms of recurrent aphthous stomatitis. Spec Care Dentist 2008;28(1):27-31.
  360. Klasser GD, Fischer DJ, Epstein JB. Burning mouth syndrome: recognition, understanding, and management. Oral Maxillofac Surg Clin N AM 2008;20:255-71.
  361. Fischer DJ, Klasser GD, Epstein JB. Cancer and orofacial pain. Oral Maxillofac Surg Clin N Am 2008;20:287-301.
  362. Agulnik M, Epstein JB. Nasopharyngeal carcinoma: Current management, future directions and dental implications. Oral Oncol 2008 (7); 617-27.
  363. Epstein JB, Gorsky M, Cabay RJ, Day T, Gonsalves W. Screening and diagnosis of oral premalignant lesions and oropharyngeal squamous cell carcinoma: Role of primary care physicians. Canadian Family Phys 2008;54: 1-6.
  364. Agulnik M, McGann CF, Mittal BB, Gordon SC, Epstein JB. Management of salivary gland malignancies: current and developing therapies. Oncol Rev 2008;2:87-95.
  365. Klasser GD, Utsman R, Epstein JB. Bilateral taste change associated with a dental procedure: case report and review of the literature.  J Canada Dent Assoc 2008; 74(5): 455-61.
  366. Patton LL, Epstein JB, Kerr RA. A systematic review of the literature: examination and lesion diagnosis. J Am Dent Assoc 2008;139;896-905.
  367. Utsman RA, Epstein JB, Elad S. Budesonide for local therapy of complex oral mucosal immune-mediated inflammatory diseases: case reports. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;106(1):E11-17.
  368. Scully C, Bagan JV, Hopper C, Epstein JB. Oral cancer: Current and future diagnostic techniques. Am J Dent 2008;21:199-209.
  369. Epstein JB, Villines D, Drahos G, Kaufman E, Gorsky M. Oral lesions in patients participating in an oral examination screening week at an urban dental school. J Am Dent Assoc 2008; 139:12338-44.
  370. Klasser GD, Utsman R, Epstein JB. Bilateral taste change associated with a dental procedure: case report and review of the literature.  Texas Dent J 2008;125:678-87.
  371. Cramer CK, Klasser GD, Epstein JB, Sheps SB. The Delphi process in dental research. J Evid Base Dent Pract 2008;8:211-20.
  372. Elting LS, Keefe DM, Sonis ST, Garden AS, Spijkervet FL, Barasch A, Tishler RB, Canty TP, Kudrimoti MK, Vera-Llonch M, for Burden of Illness Head and Neck Writing Committee (Barash A, Brennan M, Calais G, Canty T, Elting LS, Epstein J, Feyer P, Garden A, Grundberg SM, Keefe DM, Kudrimoti M, Malassiotis A, Oster G, Raber-Durlacher JE, Schultz C, Sonis ST, Spijkervet F, Tishler R, Trotti A, Vera-Llonch M). Patient-reported Measurements of Oral Mucositis in Head and Neck Cancer Patients Treated with Radiotherapy With or Without Chemotherapy: Demonstration of Increased Frequency, Severity, Resistance to Palliation, and Impact on Quality of Life. Cancer 2008;113:2704-13.
  373. LeHew C, Epstein JB, Koerber A, Kaste LM. Training in the primary prevention and early detection of oral cancer: pilot study of the impact of oral cancer prevention and early detection training on medical clinicians’ perceptions and intentions. Ear Nose & Throat 2009;88(1):748-53.
  374. Epstein JB. Cancer Care. Dimensions of Dental Hygiene 2009; February, 48-50.
  375. Barasch A, Epstein J, Tilashalski K. Palifermin for management of treatment-induced oral mucositis in cancer patients. Biologics: Targets & Therapy 2009;3:111-116.
  376. Epstein JB, Silverman S Jr, Sciubba J, Epstein JD, Bride M. Defining the risk of oral premalignant lesions. Oral Oncol 2009;45:297-8.
  377. Epstein JB, Raber-Drulacher JE, Wilkins A, Chavarria MG, Myint H. Advances in hematologic stem cell transplant: an update for oral health care providers. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;107(3):301-12.
  378. Epstein JB, Guneri P. The adjunctive role of toluidine blue in detection of oral premalignant and malignant lesions. Curr Opin Otolaryngol Head Neck Surg 2009;17(2):79-87.
  379. Epstein JB, Murphy BM. Late effects of radiation treatment on oral health for patients with head and neck cancer. American Soc Clin Oncol Ed Book 2009; 312-9.
  380. Rankin KV, Epstein J, Huber MA, Peterson DE, Plemons JM, Redding SS, Sanfillippo NJ, Schubert MM, Sonis ST. Oral health in cancer therapy. Tex Dent J 2009 May;126(5):389-97, 406-19, 422-37.
  381. Laudenbach JM, Epstein JB. Treatment strategies for oropharyngeal candidiasis. Expert Opin Pharmacother 2009(9):1413-21.
  382. Epstein JB, Wilkie DJ, Fischer DJ, Kim Y-O. Neuropathic and nociceptive pain in head and neck cancer patients receiving radiation therapy. Head & Neck Oncology 2009, 1:26 doi:10.1186/1758-3284-1-26.
  383. Murphy BA, Beaumont JL, Isitt J, Garden AS, Gwede CK, Trotti AM, Meredith RF, Epstein JB, Le Q-T, Brizel DM, Bellm LA,  Wells N, Cella D. Mucositis-related morbidity and resource utilization in head and neck cancer patients receiving radiation therapy with or without chemotherapy. J Pain Symp Manage 2009;38(4):522-532.
  384. Klasser GD, Epstein JB. Evaluation of severe acute pain and conventional dental interventions. J Can Dent Assoc 2009 Jul;75(6):444-6.
  385. Napenas JJ, Lockhart PB, Epstein JB. Comment on the 2009 American Academy of Orthopaedic Surgeons’ information statement on antibiotic prophylaxis for bacteremia in patients with joint replacements. J Can Dent Assoc 2009 Jul;75(6):447-9.
  386. Klasser GD, Epstein JB, Utsman R, Yao M, Nguyen PH. Parotid gland squamous cell carcinoma invading the temporomandibular joint. J Am Dent Assoc 2009;140:992-99.
  387. Fischer DJ, Epstein JB, Klasser G. Multiple sclerosis: an update for oral health care providers. Oral Surg Oral Med oral Pathol oral Radiol Endod 2009;108(3):318-27.
  388. LeHew CW, Epstein JB, Kaste L, Choi Y-K. Assessing oral cancer early detection: clarifying dentists’ practices. J Pub Health Dentistry 2009; Sept 17 epub ahead of print.
  389. Epstein JB, Barasch A. Taste disorders in cancer patients: Pathogenesis, and approach to assessment and management. Oral Oncol 2010;46(2):77-81.
  390. Guneri P, Epstein JB. The need to reassess studies on detection of potentially premalignant and malignant oral lesions. Oral Oncol 2010;46(1);e2-3.
  391. Lacouture ME, Maitland ML, Segaert S, Setser A, Baran R, Fox LP, Epstein JB, Barasch A, Einhorn L, Wagner L, West DP, Rapoport BL, Kris MG, Basch E, Eaby B, Kurtin S, Olsen EA, Chen A, Dancey JE, Trotti A. A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study group. Support Care Cancer 2010;18(4):509-22.
  392. Silverman S Jr, Kerr AR, Epstein JB. Oral and pharyngeal cancer control and early detection. J Cancer Educ DOI 10.1007/s13187-010-0045-6 Mar 05, 2010. [Epub ahead of print]
  393. Guneri P, Epstein JB, Ergun S, Boyacioglu H. Toluidine blue color perception in identification of oral mucosal lesions. Clin Oral Investig 2010; Mar 25 [Epub ahead of print] PMID 203326473
  394. Rethman MP, Carpenter W, Cohen EEW, Epstein J, Evans CA, Flaitz CM, Graham FJ, Hujoel PP, Kalmar JR, Koch WM, Lambert PM, Lingen MW, Oettmeier Jr BW, Patton LL, Perkins D, Reid BC, Sciubba JJ, Tomar SL, Wyatt Jr AD, Aravamudhan K, Frantsve-Hawley J, Cleveland JL, Meyer DM, for the American Dental Association Council on Scientific Affairs, Expert Panel on Screening for Oral Squamous Cell Carcinomas. Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas. J Am Dent Assoc 2010;141:509-20.
  395. Fischer DJ, Villines D, Kim YO, Epstein JB, Wilkie DJ. Anxiety, depression and pain: differences by primary cancer. Support Care Cancer 2010; 18:801–810. DOI 10.1007/s00520-009-0712-5.
  396. Yarom N, Epstein J, Levi H, Porat D, Kaufman E, Gorsky M. Oral manifestations of habitual khat chewing: a case-control study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Jun;109(6):e60-6.
  397. Epstein JB, Hong C, Logan RM, Barasch A, Gordon SM, Oberlee-Edwards L, McGuire D, Napenas JJ, Elting LS, Spijkervet FK, Brennan MT. A systematic review of orofacial pain in patients receiving cancer therapy. Support Care Cancer 2010 18:1023-31. DOI 10.1007/s00520-010-0897-7
  398. Wilder-Smith P, Holtzman J, Epstein J, Le A. Optical diagnostics in the oral cavity: an overview. Oral Dis. 2010 Jun 18. [Epub ahead of print] PMID 20561224
  399. Greene CS, Klasser GD, Epstein JB. Revision of the American Association of Dental Research's Science information statement on temporomandibular disorders. J Canad Dent Assoc 2010; 76:a115. 
  400. Epstein MS, Wicknick FW, Epstein JB, Berenson JR, Gorsky M. Management of bisphosphonate-associated osteonecrosis: pentoxifylline and tocopherol in addition to antimicrobial therapy. An initial case series. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010;110:593-6. 
  401. Vasquez JA, Patton LL, Epstein JB, Ramlachan P, Mitha I, Noveljic Z, Fourie J, Conway B, Lalla RV, Barasch A, Attali P. Randomized, comparative, double-blind, double-dummy, multicenter trial of miconazole buccal tablet and clotrimazole troches for the treatment of oropharyngeal candidiasis: Study of Miconazole Laruriad efficacy and safety (SMiLES). HIV Clin Trials 2010; 11(4):186-96. 
  402. Cilurzo F, Gennari CGM, Selmin F, Epstein JB, Gaeta GM, Colella G, Minghetti P.  A new mucoadhesive dosage form for the management of oral lichen planus: formulation study and clinical study. Europ J Pharmaceut Biopharmaceut 2010;76:437-42. . [Epub ahead of print] PMID:20708076
  403. Elad S, Epstein JB, Yarom N, Drucker S, Tzach R, Bultzingslowen I. Topical immunomodulators for management of oral mucosal conditions, a systematic review; part 1: calcineurin inhibitors. Expert Opin Emerg Drugs. 2010;15(4):713-26. 
  404. Epstein JB, Murphy BA. Late effects of cancer and cancer therapy on oral health and quality of life. J Mass Dent Soc 2010;59(3):22-7. 
  405. Epstein JB, Klasser GD, Kolbinson DA, Mehta SZ, Johnson BR. Orofacial injuries due to trauma following motor vehicle collisions: Part 1. Traumatic dental injuries. J Can Dent Assoc 2010;76:a171. 
  406. Epstein JB, Klasser GD, Kolbinson DA, Mehta SA. Orofacial injuries due to trauma following motor vehicle collisions: part 2. Temporomandibular disorders. J Can Dent Assoc 2010; 76:a172. 
  407. Guneri P, Epstein JB, Kaya A, Veral A, Kazandi A, Boyacioglu H. The utility of toluidine blue staining and brush cytology as adjuncts in clinical examination of suspicious oral mucosal lesions. Int J Oral Maxillofac Surg 2011;40(2):155-61. doi:10.1016/j.ijom.2010/10/022 
  408. Migliorati CA, Epstein JB, Abt E, Berenson JR. Osteonecrosis of the jaw and bisphosphonates in cancer: a narrative review. Nat Rev Endocrinol 2011;7(1):34-42. PMID 21079615.
  409. Chainani-Wu N, Epstein J, Tougher-Decker R. Diet and prevention of oral cancer: strategies for clinical practice. J Am Dent Assoc 2011;142(2): 166-9
  410. Minor JS, Epstein JB. Burning mouth syndrome and secondary oral burning. Otolaryngol Clin N Am 2011;44(1):205-19. 
  411. Epstein JB, Klasser GD. Whiplash-associated disorders and temporomandibular symptoms following motor-vehicle collisions. Quintessence Int 2011;42(1):e1-14. PMID:21206925 [PubMed – in process]..
  412. Cheng KK, Lee V, Li CH, Goggins W, Thompson DR, Yuen HL, Epstein JB. Incidence and risk factors of oral mucositis in paediatric and adolescent patients undergoing chemotherapy. Oral Oncol 2011;47(3):153-62. [Epub ahead of print] PMID 21220206.
  413. Elad S, Epstein JB, von Bultizingslowen I, Drucker S, Tzach R, Yarom N. Topical immunodulators for management of oral mucosal conditions, a systematic review; part II: miscellaneous agents. Expert Opin Emerg Drugs 2011; 16(1):183-02. Jan 19 [Epub ahead of print]. PMID: 21244328. 
  414. Le A, Messadi D, Epstein J, Wilder-Smith P. Toward multimodality oral cancer diagnosis in the XXI century: Blending cutting edge imaging and genomic/proteomic definition of suspicious lesions. Bioinformation 2011; 5(7):304-6. 
  415. Gorsky M, Epstein JB. Oral lichen planus: malignant transformation and human papilloma virus: a review of potential clinical implications. Oral Surg Oral Med Oral Pathol Radiol Endod 2011; 111:461-4. [Epub ahead of print] PMID:21244328.
  416. Watters AL, Epstein JB, Agulnik M. Oral complications of targeted cancer therapies: A narrative literature review. Oral Oncol 2011; Apr 20 [epub ahead of print] PMID 21514211.
  417. Klasser GD, Epstein JB, Villines D, Utsman R. Burning mouth syndrome: A challenge for dental practitioners and patients. General Dent 2011;59(3):210-22. 
  418. Bensadoun RJ, Patton LL, Lalla RV, Epstein JB. Oropharyngeal candidiasis in head and neck cancer patients treated with radiation: update 2011. Support Care Cancer 2011; 19(6):737-44; DOI 10.1007/s00520-011-1154-4.
  419. Karavana Hizarcioglu SY, Sezer B, Guneri P, Veral A, Boyacioglu H, Ertan G, Epstein JB. Efficacy of topical benzydamine hydrochloride gel on oral mucosal ulcers: an in vivo animal study. Int J Oral Maxillofac Surg 2011 May 4 [Epub ahead of print]: PMID: 21549562. 
  420. Kolokythas, A, Schwartz JL, Pytynia KB, Panda S, Yao M, Homann B, Sroussi HY, Epstein JB, Gordon SC, Adami GR. Analysis of RNA from brush cytolotgy detects changes in B2M, CYP1B1 and KRT17 levels with OSCC in tobacco users. Oral Oncol 2011 May 4 [Epub ahead of print]; PMID:21549635.  
  421. Lacouture ME, Anadkat MJ, Bensadoun R-J, Bryce  J, Chan A, Epstein JB, Eaby-Sandy B, Murphy BA, MASCC Skin toxicity Study Group. Clinical practice guidelines for the prevention and treatment of EGFR inhibitor associated dermatologic toxicities. Support Care Cancer 2011Jun 1[Epub ahead of print] PMID 21630130. 
  422. Klasser GD, Epstein JB. Neuralgia-inducing cavitational osteonecrosis: A possible diagnosis for an Orofacial pain complaint? J Am Dent Assoc 2011;142(6):651-3. 
  423. Guneri P, Alpoz E, Epstein JB, Cankaya H, Ates M. In vitro antimicrobial effects of commercially available mouth-wetting agents. Spec Care Dentistry 2011;21:123-8. DOI:10.1111/j. 1754-4505.2011.00194.x.
  424. Cleveland JL, Junger ML, Saralya M, Markowitz LEW, Dunne EF, Epstein JB. The connection between human papillomavirus and oropharyngeal squamous cell carcinomas in the United States: Implications for dentistry. J Am Dent Assoc 2011;142(8):915-24.
  425. Barasch A, Epstein JB. Management of cancer treatment oral mucositis. Dermatol Ther 2011;24(4):424-31.
  426. Epstein JB, Huhmann MB. Dietary and nutritional needs of patients undergoing therapy for head and neck cancer. J Am Dent Assoc 2011; 142(10):1163-7.
  427. Le D, Le A, Holtzman J, Epstein J, Wilder-Smith P. Optical imaging in the oral cavity: Innovatie and emergent imaging techniques. Laser 2011;3:24-29.
  428. Klasser GD, Epstein JB, Villines D. Diagnostic dilemma: The enigma of an oral burning sensation. J Can Dent Assoc 2011;77(6):363-4, 366 (b146).
  429. Klasser GD, Epstein JB, Villines D. Management of burning mouth syndrome. J Can Dent Assoc 2011;77(6):365. (b151)
  430. Elad, S, Epstein JB, Raber-Durlacher J, Donnelly P, Strahilevitz J. The antimicrobial effect of Iseganan HCl oral solution in patients receiving stomatotoxic chemotherapy: analysis from a multicenter, double-blind, placebo-controlled, randomized, phase III clinical trial. J Oral Pathol Med 2012;41(3):229-34.
  431. Cooperstein E, Gilbert J, Epstein JB, Dietrich MS, Bond SM, Ridner SH, Wells N, Cmelak A, Murphy BA. Vanderbilt head and neck symptom survey version 2.0: Report of the development and initial testing of a subscale for assessment of oral health. Head Neck 2012;34(6):797-804.
  432. Cheng KK, Lee V, Li CH, Yuen HL, Epstein JB. Oral mucositis in pediatric and adolescent patients undergoing chemotherapy: the impact of symptoms on quality of life. Support Care Cancer 2012;20(10):2335-42
  433. Boers-Doets CB, Epstein JB, Raber-Durlacher JE, Ouwerker K, Logan RM, Brakenhoff JA, Lacouture ME, Golderblom H. Oral adverse events associated with tyrosine kinase and Mammalian target of rapmycin inhibitors in renal carcinoma: a structure literature review. Oncologist 2012;17(1):135-44.
  434. Jacobson JJ, Epstein JB, Eichmiller FC, Gibson TB, Carls GS, Vogtmann E, Wang S, Murphy B. The cost burden of oral, oral pharyngeal, and salivary gland cancers in three groups: commercial insurance, Medicare, and Medicaid. Head Neck Oncol 2012;26;4(1):15.
  435. Epstein JB, Huhmann MB. Dietary and nutritional needs of patients after therapy for head and neck cancer. J Am Dent Assoc 2012;143(6):588-92.
  436. Ganzer H, Touger-Decker R, Parrott JS, Murphy BA, Epstein JB, Huhmann ME. Symptom burden n head and neck cancer: impact upon oral energy and protein intake. Support Care Cancer Epub ahead of print: July 24, 2012 DOI 10.1007/s00520-012-1542-4.
  437. Epstein MS, Epstein JB, Ephros HD. The effects of osteoclast modifiers on the oral cavity: a review for prescribers. Curr Opin Support Palliat Care 2012; 6(3):337-41.
  438. Epstein MS, Ephros HD, Epstein JB. Review of current literature and implications of RANKL inhibitors for oral health care providers. Oral Surg Oral Med Oral Pathol Oral Radiol 2012 Aug 15;[Epub ahead of print] PMID: 22901640
  439. Epstein JB, Thariat J, Bensadoun RJ, Barasch A, Murphy BA, Kolnick L, Popplewell L, Maghami E. Oral complications of cancer and cancer therapy: From cancer treatment to survivorship.CA Cancer J Clin 2012;62(6):400-22.
  440. Klasser GD, Epstein JB. Oral burning and burning mouth syndrome. J Am Dent Assoc 2012; 143 (12): 1317-9.
  441. Epstein JB, Guneri P, Boyacioglu H, Abt E. The limitation of the clinical oral examination in detecting dysplastic oral lesions and oral squamous cell carcinoma. J Am Dent Assoc 2012; 143(12): 1332-42.
  442. Raber-Durlacher JE, von Bültzingslöwen I, Logan RM, Bowen J, Al-Azri AR, Everaus H, Gerber E, Gomez JG, Pettersson BG, Soga Y, Spijkervet FK, Tissing WJ, Epstein JB, Elad S, Lalla RV; For the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients. Support Care Cancer 2013;21(1):343-55.
  443. Raber-Durlacher JE, Laheij AM, Epstein JB, Epstein M, Geerligs GM, Wolffe GN, Blijlevens NM, Donnelly JP. Periodontal status and bacteremia with oral viridans streptococci and coagulase negative staphylococci in allogeneic hematopoietic stem cell transplantation recipients: a prospective observational study. Support Care Cancer 2013;Jan [epub ahead of print] PMID: 23288398
  444. Calantog A, Hallajian L, Nabelsi T, Mansour S, Le A, Epstein J, Wilder-Smith P. A prospective study to assess in vivo optical coherence tomography imaging for early detection of chemotherapy-induced oral mucositis. Laser Surg Med 2012 Jan 15. doi:10.1002/lsm.22111[Epub ahead of print] PMID 23322707
  445. Boers-Doets CB, Gelderblom H, Lacouture ME, Epstein JB, Nortier JWR, Kaptein AA. Experiences with the FACT-EGFRI-18 instrument in EGFRI-associated mucocutaneous adverse events. Support Care Cancer DOI 10.1007/s00520-013-1752-4.
  446. Epstein J, Guneri P, Botto RW.  Breaking bad medical news in a dental care setting. JAm Dent Assoc. 2013 Apr;144(4):3816.
  447. Cheng KK, Lee V, Li CH, Yuen HL, Ip WY, He HG, Epstein JB. Impact of oral mucositis on short-term clinical outcomes in paediatric and adolescent patients undergoing chemotherapy. Support Care Cancer 2013; 21:2145-52.
  448. Guneri P, Epstein JB, Ilhan B, Kaya A, Boyacioglu H. Clinical application of a digital method to improve the accuracy of color perception to toluidine blue stained oral mucosal lesions. Quintessence Int 2013; 44:619-27; DOI 10.32901/j.qi.a29510.
  449. Boers-Doets CG, Gelderblom H, Lacouture ME, Bredle JM, Epstein JB, Schrama NA, Euwerkerk J, Gall H, Brakenhoff JA, Nortier JW, Kaptein AA. Translation and linguistic validation of the FACT-EGFRI-18 quality of life instrument from English into Dutch.  Europ J Oncol Nurs 2013; PMID 23571163 (epub ahead of print).
  450. Epstein JB, Saunders D. Management of unilateral facial numbness. J Canada Dent Assoc 2013;79:d52.
  451. Alpoz E, Guneri P, Epstein JB, Cankaya H, Osmic D, Boyacioglu H. Dental students’ knowledge of characteristics and management of oral complications of cancer therapy. Support Care Cancer 2013; doi:10.1007/s00520-013-1856-x.PMID: 23729227.
  452. Epstein JB. Personalized medicine: predicting the risk of complications of cancer therapy. Oral Disease 2013 doi:10.1111/odi.12147.
  453. Saunders DP, Epstein JB, Elad SA, Allemano J, Bossi P, van de Wetering MD, Rao NG, Potting C, Cheng KK, Freidank A, Brennan MT, Bowen J, Dennis K, Lalla RV; For The Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients. Support Care Cancer 2013;Jul 6 (Epub ahead of print) PMID 23832272.
  454. Wong RKS, Bensadoun R-J, Boers-Doets CB, Bryce J, Chan A, Epstein JB, Eaby-Sandy B, Lacouture ME. Clinical practice guidelines for the prevention and treatment of acute and late radiation reactions from the MASCC Skin Toxicity Study Group. Support Care Cancer 2013, August 14 PMID 23942595.
  455. Epstein JB, Guneri P, Boyacioglu H, Abt E. The limitation of the clinical oral examination in detecting dysplastic oral lesions and oral squamous cell carcinoma. Tex Dent J 2013;130(5):410-24.  Reprint from J Am Dent Assoc 2012.
  456. Klasser GD, Gremillion HA, Epstein JB. Dental treatment for patients with neuropathic orofacial pain. J Am Dent Assoc 2013; 144(9): 1006-8.
  457. Klasser GD, Pinto A, Czyscon JM, Cramer CK, Epstein J. Defining and diagnosing burning mouth syndrome: Perceptions of directors of North American postgraduate oral medicine and orofacial pain programs. J Am Dent Assoc 2013;144(10):1135-42.
  458. Fischer DJ, Epstein JB, Yao Y, Wilkie DJ. Oral health conditions affect functional and social activities of terminally ill cancer patients. Support Care Cancer 2013 Nov 14 PMID 24232310.
  459. Kolnick L, Deng J, Epstein JB, Migliorati CA, Rezk J, Dietrich MS, Murphy BA. Associations of oral health items of the Vanderbilt Head and Neck Symptom Survey with a dental health assessment. Oral Oncol 2013, doi 10.019.
  460. Boers-Doets CB, Raber-Durlacher JE, Treister NS, Epstein JB, Arends ABP, Weirsma IP, Lalla RV, Logan RM, van Erp NP, Gelderblom H. Mammalian target of rapamycin inhibitor associated mucositis. Future Oncol 2013;9(12):1883-92.
  461. Epstein JB, Gordon S. Managing patients with red or red-white oral lesions. J Can Dent Assoc 2013; Nov:79:d95 PMID 24309063
  462. Lewis SL, Brody R, Touger–Decker R, Parrott JS, Epstein J. (2014), Feeding tube use in patients with head and neck cancer. Head Neck.doi: 10.1002/hed.23538
  463. Lalla RV, Bowen J, Barasch A, Elting L, Epstein J, Keefe DM, McGuire DB, Migliorati C, Nicolatou-Galitis O, Peterson DE, Raber-Durlacher JE, Sonis ST, Elad S; The Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology  (MASCC/ISOO). MASCC/ISOO  clinical practice guidelines for the management of mucositis secondary to cancer therapy .Cancer 2014; Feb 25.doi: 10.1003.cncr.28592 [Epub ahead of print]
  464. Epstein JB, Guneri P, Barasch A. Appropriate and necessary oral care for people with cancer: guidance to obtain the right treatment at the right time. Support Care Cancer Mar 28, 2014; doi 10.10076.s00520-014-2228-x PMID 24676676 [Epub ahead of print]
  465.  Haverman TM, Raber-Durlacher JE, Rademacher WM, Vokurka s, Epstein JB, Huisman C, Hazenberg MD, de Soet JJ, de Lange J, Rozema FR. Oral complications in hematopoietic stem cell recipients: The role of inflammation. Mediators inflamm 2014;2014:378281. Epub 2014 Apr 10.
  466. Walega DR, Smith C, Epstein JB. Bilateral stellate ganglion blockade for recalcitrant oral pain from burning mouth syndrome: a case report. J Oral Facial Pain Headache. 2014;28(2):171-5. doi: 10.11607/ofph.1165.
  467.  Alpöz E, Cankaya H, Güneri P, Epstein JB, Boyacioglu H, Kabasakal Y, Ocakci PT. Impact of Buccotherm® on xerostomia: a single blind study. Spec Care Dentist 2014 May 18. Doi: 10.1111/scd.12074. [Epub ahead of print]
  468. Epstein JB. Screening for oral potentially malignant epithelial lesions and squamous cell carcinoma: A discussion of benefit and risk. J Canad Dent Assoc 2014;80:e47.
  469. Elad S, Raber-Durlacher JE, Brennan MT, Saunders DP, Mank AP, Zadik Y, Quinn B, Epstein JB, Blijlevens NM, Waltimo T, Passweg JR, Correa ME, Dahllof G, Garming-Legert KU, Logan RM, Potting CM, Shapira MY, Soga Y, Stringer J, Stokman MA, Vokurka S, Wallhult E, Yarom N, Jensen SC. Basic oral care for hematology-oncology patients and hematopoietic stem cell transplantation recipients: a position paper from the joint task force of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT). Support Care Cancer 2014 Sep 5 (Epub ahead of print) PMID 2518949
  470. Conkaya H, Guneri P, Epstein JB. Adjunctive methods and devices for clinical detection of oral squamous cell carcinoma.  Oral Health Prev Dent 2014; Sep 5 doi:10.3290/j.ohpd.a32667 [Epub ahead of print] PMID25197727
  471. Bensadoun R-J, Epstein J. Place du LLLT dans la prise en charge preventive et curative des mucitis induites par les traitements anti-cancereux en Europe et aux Etrats-Unis: etat des lieux en 2014. Revue des Transatlantiques en Oncologie 2014(2):37-9.
  472. Elad S, Jensen SB, Raber-Durlacher JE, Mouradian N, Correa EM, Schubert MM, Blijlevens NM, Epstein JB, Saunders JB, Waltimo T, Zadik Y, Brennan MT. Clinical approach in the management of oral chronic graft-versus-host disease (cGVHD) in a series of specialized medical centers. Support Care Cancer 2014 Nov 23 PMID 25417941
  473. Donaldson M, Epstein J, Villines D. Managing the care of patients with Sjogren syndrome and dry mouth: comorbidities, medication use and dental care considerations. J Am Dent Assoc 2014 Dec;145(12):1240-7. Doi:10.14219/jada.2014.83. 
  474. Jackson LK, Johnson DB, Sosman JA, Murphy BA, Epstein JB. Oral health in oncology: impact of immunotherapy. Support Care Cancer 2015; 23:1-3. PMID 25216852
  475. Chan A, Cameron MC, Garden B, Boers-doets CB, Schindler K, Epstein JB, Choi J, beamer L, Roeland E, Russi EG, Bensadoun RJ, Teo YL, Chan RJ, Shih V, Bryce J, Raber-Durlacher J, Gerber PA, Freytes CO, Rapoport B, LeBoeuf N, Sibaud V, Lacouture ME. A systematic review of patient-reported outcome instruments of dermatologic adverse events associated with targeted cancer therapies. Support Care Cancer 2015; 23:2231-44. doi: 10.1007/s00520-014-2564-x
  476. Epstein JB, Villines DC, Sroussi HY. Oral symptoms and oral function in people with Sjogren’s syndrome. Clin Exp Rheumatol 2015; 33(1):132-3 PMID:25572418
  477. Donaldson M, Goodchild JH, Epstein JB. Sugar content, cariogenicity, and dental concerns with commonly used medications.  J Am Dent Assoc 2015; 146(2):129-133.
  478. Ip WY, Epstein JB, Lee V, Yuen HL, Li R, Thompson DR, Goggins WW, Cheng KK.  Oral mucositis in pediatric patients after chemotherapy for cancer.  Hong Kong Med J 2014;Dec 20 Suppl 7:4-8.
  479. Epstein JB, Sciubba JJ, Abt E. Evidence base, epidemiology, correlation and cause and effect: Dental caries and head and neck cancer. Oral Surg Oral Med Oral Pathol Oral Radiol 2014;118(1):1-4.
  480. Epstein JB, Kish RV, Hallajian L, Sciubba J. Head and neck, oral, and oropharyngeal cancer: a review of medicolegal cases. Oral Surg Oral Med Oral Pathol Oral Radiol 2015;119:177-86.
  481.  Coa KI, Epstein JB, Ettinger D, Jatoi A, McManus K, Platek ME, Price W, Stewart M, Teknos TN, Moskowitz B. The impact of cancer therapy on the diets and food preferences of patients receiving outpatient therapy. Nutrition and Cancer 2015; doi: 10.1080/01635581.2015.99057
  482. Nguyen DT, Shayani S, Palmer J, Dagis A, Forman SJ, Epstein J, Spielberger R. Palifermin for prevention of oral mucositis in allogeneic hematopoietic stem cell transplantation: a single-institution retrospective evaluation. Support Care caner 2015; Mar 21. PMID: 25791390.
  483. Ganzer H, Touger-Decker R, Byham-Gray L, Murphy BA, Epstein JB. The eating experience after treatment for head and neck cancer: A review of the literature. Oral Oncol 2015; 51:634-42. doi: 10.1016/j.oraloncology.2015.04.014
  484. Epstein JB, Villines DC, Sroussi HY. Patient reported outcomes of the clinical use of a proprietary topical dry mouth product.  Spec Care Dentist 2015;35(4);197-204. doi: 10.1111/scd.12112.
  485. Fitzgerald J, Epstein JB, Donaldson M, Schwartz G, Jones C, Fung K. Outpatient medication use and implications for dental care: Guidance for contemporary dental practice. J Can Dent Assoc 2015;81:f10
  486. Chainani-Wu N, Madden E, Cox D, Sroussi H, Epstein J, Silverman S Jr. Toluidine blue aids in detection of dysplasia and carcinoma in suspicious oral lesions.  Oral Disease 2015;Jul 14. Doi: 10.1111/odi.12358.
  487. Jackson LK, Epstein JB, Migliorati CA, Rezk J, Shintaku WH, Noujeim ME, Santos-Silva AR, Dietrich MS, Murphy BA. Development of tools for the oral health and panoramic evaluation of the head and neck cancer patient: A methodological study.  Spec Care Dentist 2015;Jul 14. Doi: 10.1111/scd. 12125.
  488. Guneri P, Epstein JB, Raber-Durlacher JE, Cankaya H, Boyacioglu H, Barasch A.  Patient reported outcomes for immediate identification of dental needs. Forum Clin Oncol 2015;2(6):1-7. doi: 10.1515/fco-2015-0006
  489. Epstein JB, Saunders DP. Managing oral mucositis: Cancer Therapy. Oral Health 2015;8-10,12.
  490.  Deng J, Jackson L, Epstein JB, Migliorati CA, Murphy BA. Dental demineralization and caries in patients with head and neck cancer. Oral Oncol 2015 Jul 18. pii: S1368-8375. doi: 10.1016/j.oraloncology.2015.06.009
  491. Klasser GD, Epstein JB. How to manage “closed lock” disc displacement without reduction with limited opening.  CDA Essentials 2015;2(5); 39-41.
  492. Stapleton SJ, Holden J, Epstein J, Wilkie DJ. A systematic review of the Symptom Distress Scale in advanced cancer studies. Cancer Nurs 2015;Aug 6 PMID 26252436.
  493. Epstein JB, Beier Jensen S. Management of hyposalivation and xerostomia: Criteria for treatment strategies. Compend Contin Educ Dent 2015;36(8):600-3.
  494. Epstein JB, Huber MA. The benefit and risk of screening for oral potentially malignant epithelial lesions and squamous cell carcinoma. Oral Surg Oral Med oral Pathol Oral Radiol 2015;120(5):537-40. doi:10.1016/j.oooo.2015.07.036.
  495. Huber MA, Epstein JB. Marketing versus science: a call for evidence-based advertising in dentistry. Oral Surg Oral Med oral Pathol Oral Radiol 2015;120(5):541-3. Doi:10.1016/j.oooo.2015.07.038.
  496. Barasch A, Raber-Durlacher J, Epstein JB, Carroll J. Effects of pre-radiation exposure to LLLT of normal and malignant cells. Accepted J Support Care Cancer 2015 Dec 16 PMID:26670917.
  497. Khan Z, Epstein JB, Marur S, Gillespie MB, Feldman L, Tasi HL, Zhang Z, Wang H, Sciubba J, Ferris R, Grandis JR, Gibson M, Koch W, Tufano R, Westra W, Tsottles N, Ozawa H, Chung C, Califano JA. Cetuximab activity in dysplastic lesions of the upper aerodigestive tract. Oral Oncol 2015 Dec 10. Pii:S1368-8375(15)00394-2. Doi: 10:1016/j.oraloncology.2015.11.016.
  498. Sonis ST, Hashemi S, Epstein JB, Nair RG, Raber-Durlacher JE. Could the biological robustness of low level laser therapy (Photobiomodulation) impact its use in the management of mucositis in head and neck cancer patients. Oral Oncol 2016; 54:7-14. Doi: 10.1016/j.oraloncology 2016.01.005.
  499. Guneri P, Ilhan B, Cal E, Epstein JB, Klasser GD. Obstructive sleep apnoea and the need for its introduction into dental curricula. Eur J Dent Educ 2016;Feb 20. Doi:10.1111/eje.12190.
  500. Epstein JB, Smutzer G, Doty RL. Understanding the impact of taste changes in oncology care. Support Care Cancer 2016;24(4):1917-31. Doi 10.10007/s00520-016-3083-8.
  501. Epstein JB, Kupferman SB, Zabner R, Rejali A, Hopp ML, Lill M, Tzachanis D. Early diagnosis and successful management of oral mucormycosis in a hematopoietic stem cell transplant recipient: case report and literature review. Support Care Cancer 2016; 24(8):3343-6. (Mar14) PMID: 26971955.
  502. Stapleton SJ, Holden J, Epstein J, Wilkie DJ. A systematic review of the Symptom Distress Scale in advanced cancer studies. Cancer Nurs 2016; 39: E9-23. PMID 26252436.
  503. Zecha JA, Raber-Durlacher JE, Nair RG, Epstein JB, Sonis ST, Elad S, Hamblin MR, Barasch A, Migliorati CA, Milstein DM, Genot MT, Lansaat L, van der Brink R, Arnabat-Dominguez J, van der Molen L, Jacobi I, van Diessen J, de lange J, Smeele LE, Schubert MM, Bensadoun RT. Low level laser therapy/photobiomoduation in the management of side effects of chemoradiation therapy in head and neck cancer: Part 1: Mechanisms of action, dosimetric, and safety considerations. Support Care Cancer. 2016; 24(6): 2781-92. PMID: 26984240.
  504. Zecha JA, Raber-Durlacher JE, Nair RG, Epstein JB, Elad S, Hamblin MR, Barasch A, Migliorati CA, Milstein DM, Genot MT, Lansaat L, van der Brink R, Arnabat-Dominguez J, van der Molen L, Jacobi I, van Diessen J, de Lange J, Smeele LE, Schubert MM, Bensadoun RT. Low level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: Part 2: Proposed applications and treatment protocols. Support Care Cancer. 2016;24(6):2793-805. PMID: 26984249.
  505. Stapleton SJ, Holden J, Epstein J, Wilkie DJ. Symptom clusters in patients with cancer in the hospice/palliative care setting. Support Care Cancer 2016. PMID 27029581.
  506. Epstein JB, Gharapetian S, Rejali AR, Zabner R, Lill M, Tzachanis D. Complex management of resistant oral herpes simplex virus infection following hematopoietic stem cell transplantation: potential role of topical cidofovir. Support Care Cancer 2016; 24(8):3603-6. PMID 27165053
  507. Nasri-Heir C, Epstein JB, Touger-Decker R, Benoleil R. What should we tell patients with painful temporomandibular disorders about what to eat?  J Am Dent Assoc 2016. DOI 10.106/j.adaj 2016.04.016
  508. Ezenwa MO, Fischer DJ, Epstein J, Johnson J, Yao Y, Wilkie DJ. Caregivers’ perspectives on oral health problems of end-of-life cancer patients. Support Care Cancer 2016. DOI 10.1007/s00520-016-3328-6.
389.    Epstein JB, Barasch A. Taste disorders in cancer patients: Pathogenesis, and approach to assessment and management. Oral Oncol 2010;46(2):77-81.

390.    Guneri P, Epstein JB. The need to reassess studies on detection of potentially premalignant and malignant oral lesions. Oral Oncol 2010;46(1);e2-3.

391.    Lacouture ME, Maitland ML, Segaert S, Setser A, Baran R, Fox LP, Epstein JB, Barasch A, Einhorn L, Wagner L, West DP, Rapoport BL, Kris MG, Basch E, Eaby B, Kurtin S, Olsen EA, Chen A, Dancey JE, Trotti A. A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study group. Support Care Cancer 2010;18(4):509-22.

392.    Silverman S Jr, Kerr AR, Epstein JB. Oral and pharyngeal cancer control and early detection. J Cancer Educ DOI 10.1007/s13187-010-0045-6 Mar 05, 2010. [Epub ahead of print]

393.    Guneri P, Epstein JB, Ergun S, Boyacioglu H. Toluidine blue color perception in identification of oral mucosal lesions. Clin Oral Investig 2010; Mar 25 [Epub ahead of print] PMID 203326473

394.    Rethman MP, Carpenter W, Cohen EEW, Epstein J, Evans CA, Flaitz CM, Graham FJ, Hujoel PP, Kalmar JR, Koch WM, Lambert PM, Lingen MW, Oettmeier Jr BW, Patton LL, Perkins D, Reid BC, Sciubba JJ, Tomar SL, Wyatt Jr AD, Aravamudhan K, Frantsve-Hawley J, Cleveland JL, Meyer DM, for the American Dental Association Council on Scientific Affairs, Expert Panel on Screening for Oral Squamous Cell Carcinomas. Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas. J Am Dent Assoc 2010;141:509-20.

395.    Fischer DJ, Villines D, Kim YO, Epstein JB, Wilkie DJ. Anxiety, depression and pain: differences by primary cancer. Support Care Cancer 2010; 18:801–810. DOI 10.1007/s00520-009-0712-5.
396.    Yarom N, Epstein J, Levi H, Porat D, Kaufman E, Gorsky M. Oral manifestations of habitual khat chewing: a case-control study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Jun;109(6):e60-6.
397.    Epstein JB, Hong C, Logan RM, Barasch A, Gordon SM, Oberlee-Edwards L, McGuire D, Napenas JJ, Elting LS, Spijkervet FK, Brennan MT. A systematic review of orofacial pain in patients receiving cancer therapy. Support Care Cancer 2010 18:1023-31. DOI 10.1007/s00520-010-0897-7
398.    Wilder-Smith P, Holtzman J, Epstein J, Le A. Optical diagnostics in the oral cavity: an overview. Oral Dis. 2010 Jun 18. [Epub ahead of print] PMID 20561224
399.    Cilurzo F, Gennari CG, Selmin F, Epstein JB, Gaeta GM, Colella G, Minghetti P. A new mucoadhesive dosage form for the management of oral lichen planus: Formulation study and clinical study. Eur J Pharm Biopharm 2010;Aug 11. [Epub ahead of print] PMID:20708076
400.    Greene CS, Klasser GD, Epstein JB. Revision of the American Association of Dental Research's Science information statement on temporomandibular disorders. J Canad Dent Assoc 2010; 76:a115.
401.    Epstein MS, Wicknick FW, Epstein JB, Berenson JR, Gorsky M. Management of bisphosphonate-associated osteonecrosis: pentoxifylline and tocopherol in addition to antimicrobial therapy. An initial case series. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010;110:593-6.
402.    Vasquez JA, Patton LL, Epstein JB, Ramlachan P, Mitha I, Noveljic Z, Fourie J, Conway B, Lalla RV, Barasch A, Attali P. Randomized, comparative, double-blind, double-dummy, multicenter trial of miconazole buccal tablet and clotrimazole troches for the treatment of oropharyngeal candidiasis: Study of Miconazole Laruriad efficacy and safety (SMiLES). HIV Clin Trials 2010; 11(4):186-96.
403.    Cilurzo F, Gennari CGM, Selmin F, Epstein JB, Gaeta GM, Colella G, Minghetti P.  A new mucoadhesive dosage form for the management of oral lichen planus: formulation study and clinical study. Europ J Pharmaceut Biopharmaceut 2010;76:437-42.
404.    Migliorati CA, Epstein JB, Abt E, Berenson JR. Osteonecrosis of the jaw and bisphosphonates in cancer: a narrative review. Nat Rev Endocrinol 16 November 2010 doi:10.1038/nrendo.2010.195.
405.    Minor JS, Epstein JB. Burning mouth syndrome and secondary oral burning. Otolaryngol Clin N Am 2011;44(1):205-19.
406.    Guneri P, Epstein JB, Kaya A, Veral A, Kazandi A, Boyacioglu H. The utility of toluidine blue staining and brush cytology as adjuncts in clinical examination of suspicious oral mucosal lesions. Int J Oral Maxillofac Surg 2010; doi:10.1016/j.ijom.2010/10/022

About Dr. Epstein

Read about Dr. Epstein's long history as a highly published leader in oral medicine

Services

 Joomlart ForumRead about the wide range of services provided by Dr. Epstein

Publications

Design template Dr. Epstein has been published over 600 times. Read his publications here

Contact

View the contact information for Dr. Epstein to schedule an appointment.

About Dr. Epstein Publications (list)